{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:17:00Z","timestamp":1793917020818,"version":"4.8.0"},"publisher-location":"Cham","reference-count":330,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031968822","type":"print"},{"value":"9783031968839","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-031-96883-9_1","type":"book-chapter","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T16:12:01Z","timestamp":1762704721000},"page":"1-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tuberculosis: An Ongoing Global Threat"],"prefix":"10.1007","author":[{"given":"Parissa","family":"Farnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Velayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalaledin","family":"Ghanavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poopak","family":"Farnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s44155-025-00252-y","volume":"5","author":"Y Abaynew","year":"2025","unstructured":"Abaynew Y, Ali A, Taye G (2025) Exploring the impact of the COVID-19 pandemic on the social determinants of tuberculosis in Addis Ababa, Ethiopia: a qualitative study. Discov Soc Sci Health 5:94","journal-title":"Discov Soc Sci Health"},{"issue":"8","key":"1_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"SS Abdool Karim","year":"2010","unstructured":"Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool KQ (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362(8):697\u2013706","journal-title":"N Engl J Med"},{"issue":"5","key":"1_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2153","volume":"7","author":"MG Akakpo","year":"2024","unstructured":"Akakpo MG, Neuerer M (2024) The relationship between health literacy and health-seeking behavior amongst university students in Ghana: a cross-sectional study. Health Sci Rep 7(5):e2153","journal-title":"Health Sci Rep"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"1245553","DOI":"10.3389\/fpubh.2024.1245553","volume":"12","author":"ME Akokuwebe","year":"2024","unstructured":"Akokuwebe ME, Osuafor GN, Idemudia ES (2024) Prevalence and association of HIV and tuberculosis status in older adults in South Africa: an urgent need to escalate the scientific and political attention to aging and health. Front Public Health 12:1245553","journal-title":"Front Public Health"},{"issue":"8","key":"1_CR5","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3201\/eid1608.100314","volume":"16","author":"KA Alexander","year":"2010","unstructured":"Alexander KA, Laver PN, Michel AL, Williams M, van Helden PD, Warren RM, Gey van Pittius NC (2010) Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg Infect Dis 16(8):1296\u20131299","journal-title":"Emerg Infect Dis"},{"issue":"45","key":"1_CR6","doi-asserted-by":"publisher","first-page":"40659","DOI":"10.1021\/acsomega.2c05307","volume":"7","author":"PSM Amado","year":"2022","unstructured":"Amado PSM, Woodley C, Cristiano MLS, O\u2019Neill PM (2022) Recent advances of DprE1 inhibitors against Mycobacterium tuberculosis: computational analysis of physicochemical and ADMET properties. ACS Omega 7(45):40659\u201340681","journal-title":"ACS Omega"},{"issue":"4","key":"1_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.20529\/IJME.2024.060","volume":"IX","author":"P Anirvan","year":"2024","unstructured":"Anirvan P (2024) The dire struggle: India\u2019s unfulfilled promise to eliminate tuberculosis. Indian J Med Ethics IX(4):338\u2013339","journal-title":"Indian J Med Ethics"},{"issue":"1","key":"1_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1186\/s12889-023-16259-6","volume":"23","author":"MA Appiah","year":"2023","unstructured":"Appiah MA, Arthur JA, Gborgblorvor D, Asampong E, Kye-Duodu G, Kamau EM, Dako-Gyeke P (2023) Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient\u2019s perspective. BMC Public Health 23(1):1317","journal-title":"BMC Public Health"},{"issue":"7","key":"1_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01528-20","volume":"59","author":"DT Armstrong","year":"2021","unstructured":"Armstrong DT, Parrish N (2021) Current updates on mycobacterial taxonomy, 2018 to 2019. J Clin Microbiol 59(7):e0152820","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ijtb.2023.10.002","volume":"70","author":"VK Arora","year":"2023","unstructured":"Arora VK, Jindal SK, Katiyar SK, Behra D, Talwar D, Sarin R, Dhar R, Mehta P, Bhargava S, Singhal P, Joshi S, Tiwaskar M, Nikam C, Chatterjee A, Vora A (2023) Genomic revolution: transforming tuberculosis diagnosis and treatment with the use of whole genome sequencing \u2013 a consensus statement. Indian J Tuberc 70(4):383\u2013389","journal-title":"Indian J Tuberc"},{"issue":"1","key":"1_CR11","first-page":"121","volume":"20","author":"O Auerbach","year":"1944","unstructured":"Auerbach O (1944) Acute generalized miliary tuberculosis. Am J Pathol 20(1):121\u2013136. PMID: 19970738; PMCID: PMC2033127","journal-title":"Am J Pathol"},{"issue":"1","key":"1_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12889-023-17495-6","volume":"24","author":"W Bai","year":"2024","unstructured":"Bai W, Ameyaw EK (2024) Global, regional and national trends in tuberculosis incidence and main risk factors: a study using data from 2000 to 2021. BMC Public Health 24(1):12","journal-title":"BMC Public Health"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.11604\/pamj.2013.15.120.2535","volume":"15","author":"LE Bain","year":"2013","unstructured":"Bain LE, Awah PK, Geraldine N, Kindong NP, Sigal Y, Bernard N, Tanjeko AT (2013) Malnutrition in sub-Saharan Africa: burden, causes and prospects. Pan Afr Med J 15:120","journal-title":"Pan Afr Med J"},{"issue":"2","key":"1_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/molecules26020475","volume":"26","author":"R Baptista","year":"2021","unstructured":"Baptista R, Bhowmick S, Shen J, Mur LAJ (2021) Molecular docking suggests the targets of anti-mycobacterial natural products. Molecules 26(2):475","journal-title":"Molecules"},{"issue":"1","key":"1_CR15","first-page":"E9","volume":"58","author":"I Barberis","year":"2017","unstructured":"Barberis I, Bragazzi NL, Galluzzo L, Martini M (2017) The history of tuberculosis: from the first historical records to the isolation of Koch\u2019s bacillus. J Prev Med Hyg 58(1):E9\u2013E12. PMID: 28515626; PMCID: PMC5432783","journal-title":"J Prev Med Hyg"},{"issue":"12","key":"1_CR17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1164\/rccm.201205-0960OC","volume":"186","author":"M Barnard","year":"2012","unstructured":"Barnard M, Warren R, Gey Van Pittius N, van Helden P, Bosman M, Streicher E, Coetzee G, O\u2019Brien R (2012) Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. Am J Respir Crit Care Med 186(12):1298\u20131305","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1_CR18","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1073\/pnas.1115761109","volume":"109","author":"LB Barreiro","year":"2012","unstructured":"Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y (2012) Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 109(4):1204\u20131209","journal-title":"Proc Natl Acad Sci USA"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"14144","DOI":"10.1038\/s41598-025-97027-x","volume":"15","author":"G Barteka","year":"2025","unstructured":"Barteka G, Bwayo D, Matovu JKB, Wanume B, Alunyo JP, Sseguya R, Masaba JP, Obbo JS (2025) Treatment outcomes and predictors of success for multidrug resistant tuberculosis (MDR-TB) in Ugandan regional referral hospitals. Sci Rep 15:14144","journal-title":"Sci Rep"},{"issue":"1","key":"1_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13011-024-00629-3","volume":"20","author":"J Bayigga","year":"2025","unstructured":"Bayigga J, Kakai I, Odongpiny EAL, Ddungu A, Semakula L, Nansereko M, Wiltshire CS, Stavia T, Zawedde-Muyanja S (2025) Alcohol use disorder among people diagnosed with tuberculosis in a large urban case-finding project in Central Uganda: prevalence, associated factors and challenges to treatment adherence. Subst Abuse Treat Prev Policy 20(1):10","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1_CR21","doi-asserted-by":"crossref","unstructured":"Bhutta ZA, Sommerfeld J, Lassi ZS, Salam RA, Das JK (2014) Global burden, distribution, and interventions for infectious diseases of poverty. Infect Dis Poverty (3):21","DOI":"10.1186\/2049-9957-3-21"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"1319845","DOI":"10.3389\/fmed.2024.1319845","volume":"11","author":"MY Birhanu","year":"2024","unstructured":"Birhanu MY, Bekele GM, Jemberie SS (2024) Molecular detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction in Ethiopia: a systematic review and meta-analysis. Front Med (Lausanne) 11:1319845","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"1_CR23","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/j.ijid.2009.12.003","volume":"14","author":"SM Blevins","year":"2010","unstructured":"Blevins SM, Bronze MS (2010) Robert Koch and the \u2019golden age\u2019 of bacteriology. Int J Infect Dis 14(9):e744\u2013e751","journal-title":"Int J Infect Dis"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-64371-7_1","volume":"1019","author":"D Brites","year":"2017","unstructured":"Brites D, Gagneux S (2017) The nature and evolution of genomic diversity in the Mycobacterium tuberculosis complex. Adv Exp Med Biol 1019:1\u201326","journal-title":"Adv Exp Med Biol"},{"issue":"4687","key":"1_CR25","first-page":"769","volume":"2","author":"British Medical Journal","year":"1950","unstructured":"British Medical Journal (1950) Streptomycin in the treatment of pulmonary tuberculosis: a Medical Research Council investigation. Br Med J 2(4687):769\u2013782","journal-title":"Br Med J"},{"issue":"6","key":"1_CR26","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1073\/pnas.052548299","volume":"99","author":"R Brosch","year":"2002","unstructured":"Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, Garnier T, Gutierrez C, Hewinson G, Kremer K, Parsons LM, Pym AS, Samper S, van Soolingen D, Cole ST (2002) A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 99(6):3684\u20133689","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12939-025-02566-4","volume":"24","author":"R Br\u00fcggemann","year":"2025","unstructured":"Br\u00fcggemann R, Schlumberger F, Chinshailo F, Willis M, Kadyrov A, Kalmambetova G, Chen M, Unterkircher SC, Moidunova N, Sydykova A, Fastenau A (2025) Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan \u2013 a phenomenological study. Int J Equity Health 24(1):185","journal-title":"Int J Equity Health"},{"issue":"21","key":"1_CR28","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1128\/JB.00488-09","volume":"191","author":"A Brzostek","year":"2009","unstructured":"Brzostek A, Pawelczyk J, Rumijowska-Galewicz A, Dziadek B, Dziadek J (2009) Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol 191(21):6584\u20136591","journal-title":"J Bacteriol"},{"key":"1_CR1014","doi-asserted-by":"crossref","unstructured":"Bulstra CA, Hontelez JAC, Otto M, Stepanova A, Lamontagne E, Yakusik A, El-Sadr WM, Apollo T, Rabkin M, UNAIDS Expert Group on Integration, Atun R, B\u00e4rnighausen T (2021) Integrating HIV services and other health services: a systematic review and meta-analysis. PLoS Med 18(11):e1003836. https:\/\/doi.org\/10.1371\/journal.pmed.1003836. PMID: 34752477; PMCID: PMC8577772","DOI":"10.1371\/journal.pmed.1003836"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12879-016-1451-0","volume":"16","author":"R Byng-Maddick","year":"2016","unstructured":"Byng-Maddick R, Noursadeghi M (2016) Does tuberculosis threaten our ageing populations? BMC Infect Dis 16:119","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s44263-024-00063-4","volume":"2","author":"RL Byrne","year":"2024","unstructured":"Byrne RL, Wingfield T, Adams ER, Banu S, Bimba JS, Codlin A, Atienzar AC, Garg T, John S, Gurgel RQ, Sander M, Santos VS, Squire SB, Vo LNQ, Creswell J (2024) Finding the missed millions: innovations to bring tuberculosis diagnosis closer to key populations. BMC Glob Public Health 2(1):33","journal-title":"BMC Glob Public Health"},{"issue":"11","key":"1_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nri.2017.69","volume":"17","author":"AM Cadena","year":"2017","unstructured":"Cadena AM, Fortune SM, Flynn JL (2017) Heterogeneity in tuberculosis. Nat Rev Immunol 17(11):691\u2013702","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1_CR32","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/003335491012500611","volume":"125","author":"MS Calderwood","year":"2010","unstructured":"Calderwood MS, Platt R, Hou X, Malenfant J, Haney G, Kruskal B, Lazarus R, Klompas M (2010) Real-time surveillance for tuberculosis using electronic health record data from an ambulatory practice in eastern Massachusetts. Public Health Rep 125(6):843\u2013850","journal-title":"Public Health Rep"},{"issue":"9","key":"1_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","volume":"10","author":"JA Caminero","year":"2010","unstructured":"Caminero JA, Sotgiu G, Zumla A, Migliori GB (2010) Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 10(9):621\u2013629","journal-title":"Lancet Infect Dis"},{"key":"1_CR34","doi-asserted-by":"crossref","unstructured":"Caminero JA, Cayla JA, Garc\u00eda-Garc\u00eda JM, Garc\u00eda-P\u00e9rez FJ, Palacios JJ, Ruiz-Manzano J (2017) Diagnosis and treatment of drug-resistant tuberculosis. Arch Bronconeumol (9):501\u2013509. English, Spanish","DOI":"10.1016\/j.arbr.2017.07.005"},{"issue":"2","key":"1_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1590\/s1806-37562017000000461","volume":"44","author":"ACC Carvalho","year":"2018","unstructured":"Carvalho ACC, Cardoso CAA, Martire TM, Migliori GB, Sant\u2019Anna CC (2018) Epidemiological aspects, clinical manifestations, and prevention of pediatric tuberculosis from the perspective of the end TB strategy. J Bras Pneumol 44(2):134\u2013144","journal-title":"J Bras Pneumol"},{"issue":"3","key":"1_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0366-0850(39)80016-3","volume":"33","author":"AJE Cave","year":"1939","unstructured":"Cave AJE (1939) The evidence for the incidence of tuberculosis in ancient Egypt. Br J Tuberc 33(3):142\u2013152","journal-title":"Br J Tuberc"},{"issue":"Suppl 3","key":"1_CR37","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1086\/651491","volume":"50","author":"JP Cegielski","year":"2010","unstructured":"Cegielski JP (2010) Extensively drug-resistant tuberculosis: \u201cthere must be some kind of way out of here\u201d. Clin Infect Dis 50(Suppl 3):S195\u2013S200","journal-title":"Clin Infect Dis"},{"issue":"46","key":"1_CR38","first-page":"784","volume":"39","author":"Centers for Disease Control and Prevention","year":"1990","unstructured":"Centers for Disease Control and Prevention (1990) Initial therapy for tuberculosis in the era of multidrug resistance. MMWR Morb Mortal Wkly Rep 39(46):784\u2013785","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"1_CR39","first-page":"388","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","unstructured":"Centers for Disease Control and Prevention (1991) Tuberculosis: multidrug-resistant tuberculosis\u2014New York City, 1990\u20131991. MMWR Morb Mortal Wkly Rep 40(23):388\u2013391","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 1","key":"1_CR40","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","volume":"113","author":"J Chakaya","year":"2021","unstructured":"Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PDMC, Bulabula ANH, Sam-Agudu NA, Nachega JB, Tiberi S, McHugh TD, Abubakar I, Zumla A (2021) Global tuberculosis report 2020 \u2013 reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis 113(Suppl 1):S7\u2013S12","journal-title":"Int J Infect Dis"},{"issue":"8","key":"1_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021147","volume":"5","author":"S Chakraborty","year":"2015","unstructured":"Chakraborty S, Rhee KY (2015) Tuberculosis drug development: history and evolution of the mechanism-based paradigm. Cold Spring Harb Perspect Med 5(8):a021147","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/ijmr.ijmr_382_23","volume":"Feb-157(2&3):13","author":"A Chauhan","year":"2023","unstructured":"Chauhan A, Parmar M, Dash GC, Solanki H, Chauhan S, Sharma J, Sahoo KC, Mahapatra P, Rao R, Kumar R, Rade K, Pati S (2023) The prevalence of tuberculosis infection in India: a systematic review and meta-analysis. Indian J Med Res Feb-157(2&3):135-151:135","journal-title":"Indian J Med Res"},{"issue":"6","key":"1_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2471\/BLT.23.290396","volume":"102","author":"A Chauhan","year":"2024","unstructured":"Chauhan A, Parmar M, Dash GC, Chauhan S, Sahoo KC, Samantaray K, Sharma J, Mahapatra P, Pati S (2024) Health literacy and tuberculosis control: systematic review and meta-analysis. Bull World Health Organ 102(6):421\u2013431","journal-title":"Bull World Health Organ"},{"key":"1_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103906","volume":"45","author":"SH Chauke","year":"2024","unstructured":"Chauke SH, Nzuza S, Ombinda-Lemboumba S, Abrahamse H, Dube FS, Mthunzi-Kufa P (2024) Advances in the detection and diagnosis of tuberculosis using optical-based devices. Photodiagn Photodyn Ther 45:103906","journal-title":"Photodiagn Photodyn Ther"},{"issue":"12","key":"1_CR45","doi-asserted-by":"publisher","first-page":"1399731","DOI":"10.3389\/fpubh.2024.1399731","volume":"9","author":"B Chekesa","year":"2024","unstructured":"Chekesa B, Singh H, Gonzalez-Juarbe N, Vashee S, Wiscovitch-Russo R, Dupont CL, Girma M, Kerro O, Gumi B, Ameni G (2024) Whole-genome sequencing-based genetic diversity, transmission dynamics, and drug-resistant mutations in Mycobacterium tuberculosis isolated from extrapulmonary tuberculosis patients in western Ethiopia. Front Public Health 9(12):1399731","journal-title":"Front Public Health"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"1512514","DOI":"10.3389\/fpubh.2025.1512514","volume":"13","author":"Z Chen","year":"2025","unstructured":"Chen Z, Chen X, Chang M, Lu D, Zhang L, Zheng Y (2025a) Age-period-cohort analysis and prediction of tuberculosis trends in China\u2014based on the global burden of disease 2021 data. Front Public Health 13:1512514","journal-title":"Front Public Health"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/ZOONOSES-2024-0061","volume":"5","author":"Z Chen","year":"2025","unstructured":"Chen Z, Wang T, Du J, Sun L, Wang G, Ni R, An Y, Fan X, Li Y, Guo R, Mao L, Jing W, Shi K, Cheng J, Wang Q, Nie W, Liu H, Liang J, Gong W (2025b) Decoding the WHO global tuberculosis report 2024: a critical analysis of global and Chinese key data. Zoonoses 5:1","journal-title":"Zoonoses"},{"issue":"14","key":"1_CR48","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3390\/jcm12144784","volume":"12","author":"R Cioboata","year":"2023","unstructured":"Cioboata R, Biciusca V, Olteanu M, Vasile CM (2023) COVID-19 and tuberculosis: unveiling the dual threat and shared solutions perspective. J Clin Med 12(14):4784","journal-title":"J Clin Med"},{"issue":"Suppl","key":"1_CR49","first-page":"1","volume":"5","author":"D Cirillo","year":"2016","unstructured":"Cirillo D, Cabibbe A, de Filippo MR, Trovato A, Simonetti T, Rossolini G, Tortoli E (2016) Use of WGS in Mycobacterium tuberculosis routine diagnosis. Int J Mycobacteriol 5(Suppl):1","journal-title":"Int J Mycobacteriol"},{"issue":"152","key":"1_CR50","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0107-2018","volume":"28","author":"SM Collin","year":"2019","unstructured":"Collin SM, Wurie F, Muzyamba MC, de Vries G, L\u00f6nnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D (2019) Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews. Eur Respir Rev 28(152):180107","journal-title":"Eur Respir Rev"},{"issue":"10","key":"1_CR51","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ng.2744","volume":"45","author":"I Comas","year":"2013","unstructured":"Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, Parkhill J, Malla B, Berg S, Thwaites G, Yeboah-Manu D, Bothamley G, Mei J, Wei L, Bentley S, Harris SR, Niemann S, Diel R, Aseffa A, Gao Q, Young D, Gagneux S (2013) Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 45(10):1176\u20131182","journal-title":"Nat Genet"},{"issue":"10","key":"1_CR52","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, TD MH, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M, Nix-TB Trial Team (2020) Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med 382(10):893\u2013902","journal-title":"N Engl J Med"},{"issue":"9","key":"1_CR53","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","volume":"387","author":"F Conradie","year":"2022","unstructured":"Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, Samoilova A, Skornykova S, Tudor E, Variava E, Yablonskiy P, Everitt D, Wills GH, Sun E, Olugbosi M, Egizi E, Li M, Holsta A, Timm J, Bateson A, Crook AM, Fabiane SM, Hunt R, TD MH, Tweed CD, Foraida S, Mendel CM, Spigelman M, ZeNix Trial Team (2022) Bedaquiline-pretomanid-linezolid regimens for drug-resistant tuberculosis. N Engl J Med 387(9):810\u2013823","journal-title":"N Engl J Med"},{"issue":"3","key":"1_CR54","doi-asserted-by":"publisher","first-page":"e02362","DOI":"10.1128\/jcm.02362-21","volume":"60","author":"H Cox","year":"2022","unstructured":"Cox H, Goig GA, Salaam-Dreyer Z, Dippenaar A, Reuter A, Mohr-Holland E, Daniels J, Cudahy PG, Nicol MP, Borrell S, Reinhard M (2022) Whole-genome sequencing has the potential to improve treatment for rifampicin-resistant tuberculosis in high-burden settings: a retrospective cohort study. J Clin Microbiol 60(3):e02362\u2013e02321","journal-title":"J Clin Microbiol"},{"issue":"9","key":"1_CR55","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/INF.0b013e3182933214","volume":"32","author":"AT Cruz","year":"2013","unstructured":"Cruz AT, Hwang KM, Birnbaum GD, Starke JR (2013) Adolescents with tuberculosis: a review of 145 cases. Pediatr Infect Dis J 32(9):937\u2013941","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"1_CR57","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0043-1354(98)00466-7","volume":"33","author":"M Dailloux","year":"1999","unstructured":"Dailloux M, Laurain C, Weber M, Hartemann P (1999) Water and nontuberculous mycobacteria. Water Res 33(10):2219\u20132228","journal-title":"Water Res"},{"issue":"3","key":"1_CR58","doi-asserted-by":"publisher","first-page":"1602445","DOI":"10.1183\/13993003.02445-2016","volume":"49","author":"M Dalcolmo","year":"2017","unstructured":"Dalcolmo M, Gayoso R, Sotgiu G, D\u2019Ambrosio L, Rocha JL, Borga L, Fandinho F, Braga JU, Galesi VM, Barreira D, Sanchez DA, Dockhorn F, Centis R, Caminero JA, Migliori GB (2017) Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil. Eur Respir J 49(3):1602445","journal-title":"Eur Respir J"},{"issue":"2","key":"1_CR59","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/jpdtsm.jpdtsm_6_22","volume":"1","author":"Z Daneshmandi","year":"2022","unstructured":"Daneshmandi Z, Pourdowlat G, Rekabi M, Honarpisheh P, Mirzendedel M, Sadati E et al (2022) Coronavirus disease 2019 and Mycobacterium tuberculosis reactivation and coinfections: a review of the literature. J Prevent Diagnos Treat Strateg Med 1(2):76\u201381","journal-title":"J Prevent Diagnos Treat Strateg Med"},{"issue":"11","key":"1_CR60","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.rmed.2006.08.006","volume":"100","author":"TM Daniel","year":"2006","unstructured":"Daniel TM (2006) The history of tuberculosis. Respir Med 100(11):1862\u20131870","journal-title":"Respir Med"},{"key":"1_CR61","first-page":"1","volume":"1","author":"NA Dar","year":"2024","unstructured":"Dar NA, Qadir M, Wani SA, Shah WA (2024) Chemical profile, antituberculosis, DSC, and molecular docking studies of Mentha longifolia essential oil. Nat Prod Res 1:1\u20137","journal-title":"Nat Prod Res"},{"issue":"11","key":"1_CR62","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois VA, Rubin EJ (2022) Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol 20(11):685\u2013701","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"1_CR63","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S1473-3099(21)00808-2","volume":"22","author":"AS Dean","year":"2022","unstructured":"Dean AS, Tosas Auguet O, Glaziou P, Zignol M, Ismail N, Kasaeva T, Floyd K (2022) 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward. Lancet Infect Dis 22(7):e191\u2013e196","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1_CR64","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1183\/09031936.00007814","volume":"44","author":"CM Denkinger","year":"2014","unstructured":"Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR (2014) Xpert MTB\/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 44(2):435\u2013446","journal-title":"Eur Respir J"},{"key":"1_CR65","doi-asserted-by":"crossref","unstructured":"Derakhshani N, Rezapour R, Azami-Aghdash S, Nafar H, Soleimanpour S, Tahmazi Aghdam E et al (2024[Epub ahead of print]) Factors affecting private sector engagement in achieving universal health coverage: a scoping review. Glob Health Action 17","DOI":"10.1080\/16549716.2024.2375672"},{"issue":"6","key":"1_CR66","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.tube.2015.10.001","volume":"95","author":"A Dippenaar","year":"2015","unstructured":"Dippenaar A, Parsons SDC, Sampson SL, van der Merwe RG, Drewe JA, Abdallah AM et al (2015) Whole genome sequence analysis of Mycobacterium suricattae. Tuberculosis (Edinb) 95(6):682\u2013688","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"1_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s44197-023-00166-5","volume":"14","author":"M Doh\u00e1l","year":"2024","unstructured":"Doh\u00e1l M, Dvo\u0159\u00e1kov\u00e1 V, \u0160perkov\u00e1 M, Pinkov\u00e1 M, Ghodousi A, Omrani M, Porvazn\u00edk I, Rasmussen EM, \u0160kere\u0148ov\u00e1 M, Krivo\u0161ov\u00e1 M, Wallenfels J, Konstantynovska O, Walker TM, Nikolayevskyy V, Cirillo DM, Solovi\u010d I, Mokr\u00fd J (2024) Tuberculosis in Ukrainian war refugees and migrants in The Czech Republic and Slovakia: a molecular epidemiological study. J Epidemiol Glob Health 14(1):35\u201344","journal-title":"J Epidemiol Glob Health"},{"key":"1_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115554","volume":"167","author":"W Dong","year":"2023","unstructured":"Dong W, Peng Q, Liu Z, Xie Z, Guo X, Li Y, Chen C (2023) Estrogen plays an important role by influencing the NLRP3 inflammasome. Biomed Pharmacother 167:115554","journal-title":"Biomed Pharmacother"},{"key":"1_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.775030","volume":"13","author":"N Dookie","year":"2022","unstructured":"Dookie N, Khan A, Padayatchi N, Naidoo K (2022) Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: updates on recent developments in the field. Front Microbiol 13:775030","journal-title":"Front Microbiol"},{"issue":"4","key":"1_CR70","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/cid\/cis487","volume":"55","author":"KE Dooley","year":"2012","unstructured":"Dooley KE, Mitnick CD, Ann DeGroote M, Obuku E, Belitsky V, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E, Efficacy Subgroup, RESIST-TB (2012) Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clin Infect Dis 55(4):572\u2013581","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004283","volume":"5","author":"OA D\u2019Silva","year":"2025","unstructured":"D\u2019Silva OA, Lancione S, Ananthakrishnan O, Addae A, Shrestha S, Alsdurf H, Thavorn K, Mzizi N, Vasilu A, Kay A, Mandalakas AM, Zwerling AA (2025) The catastrophic cost of TB care: understanding costs incurred by individuals undergoing TB care in low-, middle-, and high-income settings \u2013 a systematic review. PLOS Glob Public Health. 5(4):e0004283","journal-title":"PLOS Glob Public Health."},{"issue":"41","key":"1_CR71","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1016\/j.vaccine.2008.07.040","volume":"26","author":"SJ Dunachie","year":"2008","unstructured":"Dunachie SJ, Whelan KT, Alder NC, Sander CR, Hill AV, McShane H (2008) Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1. Vaccine 26(41):5269\u20135275","journal-title":"Vaccine"},{"issue":"9","key":"1_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2471\/BLT.08.058453","volume":"87","author":"C Dye","year":"2009","unstructured":"Dye C, L\u00f6nnroth K, Jaramillo E, Williams BG, Raviglione M (2009) Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 87(9):683\u2013691","journal-title":"Bull World Health Organ"},{"issue":"11","key":"1_CR73","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s13059-014-0490-3","volume":"15","author":"V Eldholm","year":"2014","unstructured":"Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Manns\u00e5ker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F (2014) Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient. Genome Biol 15(11):490","journal-title":"Genome Biol"},{"issue":"1645","key":"1_CR74","first-page":"20130437","volume":"369","author":"H Esmail","year":"2014","unstructured":"Esmail H, Barry CE 3rd, Young DB, Wilkinson RJ (2014) The ongoing challenge of latent tuberculosis. Philos Trans R Soc Lond Ser B Biol Sci 369(1645):20130437","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"2","key":"1_CR75","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/medicina58020188","volume":"58","author":"J Espinosa-Pereiro","year":"2022","unstructured":"Espinosa-Pereiro J, S\u00e1nchez-Montalv\u00e1 A, Aznar ML, Espiau M (2022) MDR tuberculosis treatment. Medicina (Kaunas) 58(2):188","journal-title":"Medicina (Kaunas)"},{"key":"1_CR76","unstructured":"European Centre for Disease Prevention and Control, World Health Organization Regional Office for Europe (2024) Tuberculosis surveillance and monitoring in Europe 2024\u20132022 data. Stockholm (ECDC) & Copenhagen (WHO ROE). Available from:"},{"issue":"1","key":"1_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","volume":"36","author":"JO Falkinham 3rd","year":"2015","unstructured":"Falkinham JO 3rd. (2015) Environmental sources of nontuberculous mycobacteria. Clin Chest Med 36(1):35\u201341","journal-title":"Clin Chest Med"},{"issue":"3","key":"1_CR78","doi-asserted-by":"publisher","first-page":"1602308","DOI":"10.1183\/13993003.02308-2016","volume":"49","author":"D Falzon","year":"2017","unstructured":"Falzon D, Sch\u00fcnemann HJ, Harausz E, Gonz\u00e1lez-Angulo L, Lienhardt C, Jaramillo E, Weyer K (2017) World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J 49(3):1602308","journal-title":"Eur Respir J"},{"issue":"14","key":"1_CR79","doi-asserted-by":"publisher","first-page":"1234785","DOI":"10.3389\/fimmu.2023.1234785","volume":"29","author":"D Falzon","year":"2023","unstructured":"Falzon D, Zignol M, Bastard M, Floyd K, Kasaeva T (2023) The impact of the COVID-19 pandemic on the global tuberculosis epidemic. Front Immunol 29(14):1234785","journal-title":"Front Immunol"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/bbrj.bbrj_86_18","volume":"2","author":"P Farnia","year":"2018","unstructured":"Farnia P, Farnia P, Ghanavi J, Zhavnerko GK, Poleschuyk NN, Velayati AA (2018) A review on the shape changes in pathogenic bacteria with emphasis on Mycobacterium tuberculosis. Biomed Biotechnol Res J 2:242\u2013246","journal-title":"Biomed Biotechnol Res J"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"45258","DOI":"10.1038\/srep45258","volume":"7","author":"T Fedrizzi","year":"2017","unstructured":"Fedrizzi T, Meehan CJ, Grottola A, Giacobazzi E, Fregni Serpini G, Tagliazucchi S, Fabio A, Bettua C, Bertorelli R, De Sanctis V, Rumpianesi F, Pecorari M, Jousson O, Tortoli E, Segata N (2017) Genomic characterization of nontuberculous mycobacteria. Sci Rep 7:45258","journal-title":"Sci Rep"},{"issue":"1","key":"1_CR82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40249-023-01157-1","volume":"12","author":"MRL Ferreira","year":"2023","unstructured":"Ferreira MRL, Bonfim RO, Bossonario PA, Maurin VP, Valen\u00e7a ABM, Abreu PD, Andrade RLP, Fronteira I, Monroe AA (2023) Social protection as a right of people affected by tuberculosis: a scoping review and conceptual framework. Infect Dis Poverty 12(1):103","journal-title":"Infect Dis Poverty"},{"issue":"10 Suppl 2","key":"1_CR83","first-page":"S231","volume":"3","author":"W Fox","year":"1999","unstructured":"Fox W, Ellard GA, Mitchison DA (1999) Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 3(10 Suppl 2):S231\u2013S279","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"1_CR84","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1164\/ajrccm\/140.3.668","volume":"140","author":"LN Friedman","year":"1989","unstructured":"Friedman LN, Filderman AE, D\u2019Aquila TG, Reynolds HY (1989) ELISA analysis of BACTEC bottles for the earlier diagnosis of tuberculosis. Am Rev Respir Dis 140(3):668\u2013671","journal-title":"Am Rev Respir Dis"},{"issue":"8","key":"1_CR85","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1073\/pnas.0511240103","volume":"103","author":"S Gagneux","year":"2006","unstructured":"Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC, Small PM (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 103(8):2869\u20132873","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1_CR86","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3892\/mmr.2022.12712","volume":"25","author":"Y Gan","year":"2022","unstructured":"Gan Y, Hu Q, Li A, Gu L, Guo S (2022) Estradiol inhibits autophagy of Mycobacterium tuberculosis-infected 16HBE cells and controls the proliferation of intracellular Mycobacterium tuberculosis. Mol Med Rep 25(6):196","journal-title":"Mol Med Rep"},{"issue":"9547","key":"1_CR87","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","volume":"368","author":"NR Gandhi","year":"2006","unstructured":"Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547):1575\u20131580","journal-title":"Lancet"},{"issue":"1","key":"1_CR88","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/MMBR.05011-11","volume":"76","author":"B Gao","year":"2012","unstructured":"Gao B, Gupta RS (2012) Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria. Microbiol Mol Biol Rev 76(1):66\u2013112","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"1_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41579-020-00469-5","volume":"19","author":"W Gao","year":"2021","unstructured":"Gao W, Zhang L (2021) Nanomaterials arising amid antibiotic resistance. Nat Rev Microbiol 19(1):5\u20136","journal-title":"Nat Rev Microbiol"},{"key":"1_CR90","first-page":"19","volume-title":"Kumar A","author":"A Garg","year":"2019","unstructured":"Garg A, Singh B, Sharma R, Singh A (2019) Kumar A, vol 20. Curr Mol Med, Selective estrogen receptor modulators (SERMs): Mechanistic insights against resistant infections, p 19"},{"issue":"5","key":"1_CR91","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5588\/ijtld.22.0687","volume":"27","author":"C Geric","year":"2023","unstructured":"Geric C, Qin ZZ, Denkinger CM, Kik SV, Marais B, Anjos A, David PM, Ahmad Khan F, Trajman A (2023) The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination. Int J Tuberc Lung Dis 27(5):367\u2013372","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"1_CR92","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s12913-021-06662-3","volume":"21","author":"F Getnet","year":"2021","unstructured":"Getnet F, Demissie M, Worku A, Gobena T, Tschopp R, Farah AM, Seyoum B (2021) Challenges in delivery of tuberculosis Services in Ethiopian Pastoralist Settings: clues for reforming service models and organizational structures. BMC Health Serv Res 21(1):627","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"1_CR93","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/ijmy.ijmy_71_25","volume":"14","author":"J Ghanavi","year":"2025","unstructured":"Ghanavi J, Farnia P (2025) Studying the effect of tumor necrosis factor-alpha and tumor necrosis factor gene polymorphisms on the incidence of tuberculosis. Intl J Mycobacteriol 14(2):89\u201395","journal-title":"Intl J Mycobacteriol"},{"issue":"10","key":"1_CR94","doi-asserted-by":"publisher","first-page":"205031212211224","DOI":"10.1177\/20503121221122437","volume":"6","author":"BT Gisso","year":"2022","unstructured":"Gisso BT, Hordofa MW, Ormago MD (2022 Sep) Prevalence of pulmonary tuberculosis and associated factors among adults living with HIV\/AIDS attending public hospitals in Shashamene Town, Oromia region, South Ethiopia. SAGE Open Med 6(10):20503121221122437","journal-title":"SAGE Open Med"},{"issue":"3","key":"1_CR96","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","volume":"32","author":"SV Gordon","year":"1999","unstructured":"Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32(3):643\u2013655","journal-title":"Mol Microbiol"},{"issue":"4","key":"1_CR97","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/jpdtsm.jpdtsm_133_23","volume":"2","author":"A Gota","year":"2023","unstructured":"Gota A, Shenoy VP, Kamath A (2023) Evaluating diagnostic utility of geneXpert ultra (Mycobacterium tuberculosis\/rifampicin), microscopy and liquid culture to isolate Mycobacterium tuberculosis and nontuberculous mycobacteria among pulmonary tuberculosis suspects. J Prevent Diagnos Treat Strateg Med 2(4):236\u2013242","journal-title":"J Prevent Diagnos Treat Strateg Med"},{"key":"1_CR98","volume":"3","author":"BH Gulumbe","year":"2025","unstructured":"Gulumbe BH, Abdulrahim A, Ahmad SK, Lawan KA, Danlami MB (2025) WHO report signals tuberculosis resurgence: addressing systemic failures and revamping control strategies. Decod Infect Transm 3:100044","journal-title":"Decod Infect Transm"},{"issue":"12","key":"1_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.807095","volume":"27","author":"Q Guo","year":"2022","unstructured":"Guo Q, Bi J, Lin Q, Ye T, Wang Z, Wang Z, Liu L, Zhang G (2022 May) Whole genome sequencing identifies novel mutations associated with Bedaquiline resistance in Mycobacterium tuberculosis. Front Cell Infect Microbiol 27(12):807095","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"1_CR100","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fmicb.2018.00067","volume":"13","author":"RS Gupta","year":"2018","unstructured":"Gupta RS, Lo B, Son J (2018 Feb) Phylogenomics and comparative genomic studies robustly support division of the genus mycobacterium into an emended genus mycobacterium and four novel genera. Front Microbiol 13(9):67","journal-title":"Front Microbiol"},{"issue":"8","key":"1_CR101","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.it.2022.06.004","volume":"43","author":"M Gupta","year":"2022","unstructured":"Gupta M, Srikrishna G, Klein SL, Bishai WR (2022) Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Trends Immunol 43(8):640\u2013656","journal-title":"Trends Immunol"},{"issue":"1","key":"1_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0010005","volume":"1","author":"MC Gutierrez","year":"2005","unstructured":"Gutierrez MC, Brisse S, Brosch R, Fabre M, Oma\u00efs B, Marmiesse M, Supply P, Vincent V (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 1(1):e5","journal-title":"PLoS Pathog"},{"issue":"9","key":"1_CR103","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1177\/0956462421992257","volume":"32","author":"Y Hamada","year":"2021","unstructured":"Hamada Y, Getahun H, Tadesse BT, Ford N (2021) HIV-associated tuberculosis. Int J STD AIDS 32(9):780\u2013790","journal-title":"Int J STD AIDS"},{"issue":"1","key":"1_CR104","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12936-024-04967-2","volume":"23","author":"T Hanscheid","year":"2024","unstructured":"Hanscheid T, del Portal R, Luyten C, Hermans SM, Grobusch MP (2024) Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end? Malar J 23(1):132","journal-title":"Malar J"},{"key":"1_CR1002","unstructured":"Hansen GA (1880) Unders\u00f8gelser angaaende Spedalskhedens Aarsager. Norsk Mag Laegevidensk 10:1\u201388"},{"issue":"4","key":"1_CR105","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/cancers14040909","volume":"14","author":"AT Harding","year":"2022","unstructured":"Harding AT, Heaton NS (2022) The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers (Basel) 14(4):909","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1_CR106","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2105\/AJPH.2010.199505","volume":"101","author":"JR Hargreaves","year":"2011","unstructured":"Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD (2011) The social determinants of tuberculosis: from evidence to action. Am J Public Health 101(4):654\u2013662","journal-title":"Am J Public Health"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/0-387-30743-5_33","volume":"3","author":"SY Hartmans","year":"2006","unstructured":"Hartmans SY, de Bont JA, Stackebrandt ER (2006) The genus Mycobacterium-nonmedical. Prokaryotes 3:889\u2013918","journal-title":"Prokaryotes"},{"key":"1_CR108","first-page":"1","volume":"3","author":"DJ Horne","year":"2025","unstructured":"Horne DJ, Inbaraj LR, Zifodya JS, Shapiro AE, Bhaskar A, Church EC, Daniel J, Kay AW, Kreniske J, Lutje V, Narayanan MKS (2025) Web annex B. 1. Low complexity automated nucleic acid amplification tests (LC-aNAATs) for detection of pulmonary TB and resistance to isoniazid\/rifampicin in adults and adolescents: a systematic review of diagnostic accuracy. WHO consolidated guidelines on tuberculosis. Module Diagnos 3:1","journal-title":"Module Diagnos"},{"issue":"10","key":"1_CR110","doi-asserted-by":"publisher","first-page":"ofac512","DOI":"10.1093\/ofid\/ofac512","volume":"9","author":"M Humayun","year":"2022","unstructured":"Humayun M, Chirenda J, Ye W, Mukeredzi I, Mujuru HA, Yang Z (2022) Effect of gender on clinical presentation of tuberculosis (TB) and age-specific risk of TB, and TB-human immunodeficiency virus coinfection. Open Forum Infect Dis 9(10):ofac512","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"1_CR111","first-page":"18","volume":"117","author":"L Hyde","year":"1972","unstructured":"Hyde L (1972) Rifampin in the treatment of pulmonary tuberculosis. Calif Med 117(6):18\u201321. PMID: 4635395; PMCID: PMC1518748","journal-title":"Calif Med"},{"key":"1_CR112","doi-asserted-by":"crossref","unstructured":"Iketleng T, Lessells R, Dlamini MT, Mogashoa T, Mupfumi L, Moyo S, Gaseitsiwe S, de Oliveira T (2018) Mycobacterium tuberculosis next-generation whole genome sequencing: opportunities and challenges. Tuberc Res Treat:2018, 1298542","DOI":"10.1155\/2018\/1298542"},{"key":"1_CR113","volume-title":"A clinician\u2019s guide to tuberculosis","author":"MD Iseman","year":"2000","unstructured":"Iseman MD (2000) A clinician\u2019s guide to tuberculosis. Lippincott Williams & Wilkins, Philadelphia. ISBN: 9780781717496"},{"issue":"2","key":"1_CR114","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/lungindia.lungindia_431_24","volume":"42","author":"N Jain","year":"2025","unstructured":"Jain N, Sharma D, Jain NK (2025) Newer research transforming 24-month treatment of MDR\/XDR-TB TO 6 months. Lung India 42(2):140\u2013146","journal-title":"Lung India"},{"issue":"5","key":"1_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004401","volume":"21","author":"LP James","year":"2024","unstructured":"James LP, Klaassen F, Sweeney S, Furin J, Franke MF, Yaesoubi R, Chesov D, Ciobanu N, Codreanu A, Crudu V, Cohen T, Menzies NA (2024) Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: a mathematical modeling analysis. PLoS Med 21(5):e1004401","journal-title":"PLoS Med"},{"issue":"2","key":"1_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030018","volume":"3","author":"P Jha","year":"2006","unstructured":"Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingra N, Peto R, RGI-CGHR Prospective Study Collaborators (2006) Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med 3(2):e18","journal-title":"PLoS Med"},{"issue":"4","key":"1_CR117","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4103\/ijmy.ijmy_98_20","volume":"9","author":"VM Jimeno","year":"2020","unstructured":"Jimeno VM, Mu\u00f1oz EC (2020) Diagnosis of atypical mycobacterial and fungal coinfection. Int J Mycobacteriol. 9(4):435\u2013437","journal-title":"Int J Mycobacteriol."},{"issue":"3","key":"1_CR118","first-page":"145","volume":"15","author":"VBJ John","year":"2025","unstructured":"John VBJ, Velayutham AK, Bordoloi P (2025) Targeted therapies\u2014a promising cure for TB, the leading deadliest infectious disease worldwide. Int J Sci Technol 15(3):145\u2013152","journal-title":"Int J Sci Technol"},{"issue":"1","key":"1_CR119","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v11i1.1831","volume":"11","author":"D Kalonji","year":"2019","unstructured":"Kalonji D, Mahomed OH (2019) Health system challenges affecting HIV and tuberculosis integration at primary healthcare clinics in Durban, South Africa. Afr J Prim Health Care Fam Med 11(1):e1\u2013e7","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"1_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2020.126674","volume":"246","author":"RD Kanabalan","year":"2021","unstructured":"Kanabalan RD, Lee LJ, Lee TY, Chong PP, Hassan L, Ismail R, Chin VK (2021) Human tuberculosis and Mycobacterium tuberculosis complex: a review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery. Microbiol Res 246:126674","journal-title":"Microbiol Res"},{"issue":"Suppl 2","key":"1_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100585","volume":"14","author":"N Kapata","year":"2025","unstructured":"Kapata N, Tembo J, Mwaba P, Nabyonga-Orem J, Ntoumi F, McHugh TD, Zumla A (2025) Undiagnosed burden of latent tuberculosis, active tuberculosis and tuberculosis-HIV co-infections in Africa\u2014status quo, needs, priorities, and opportunities. IJID Reg 14(Suppl 2):100585","journal-title":"IJID Reg"},{"issue":"5","key":"1_CR122","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/infdis\/170.5.1348","volume":"170","author":"V Kapur","year":"1994","unstructured":"Kapur V, Whittam TS, Musser JM (1994) Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis 170(5):1348\u20131349","journal-title":"J Infect Dis"},{"issue":"Pt 8","key":"1_CR123","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1099\/00221287-138-8-1717","volume":"138","author":"KE Kempsell","year":"1992","unstructured":"Kempsell KE, Ji YE, Estrada IC, Colston MJ, Cox RA (1992) The nucleotide sequence of the promoter, 16S rRNA and spacer region of the ribosomal RNA operon of Mycobacterium tuberculosis and comparison with Mycobacterium leprae precursor rRNA. J Gen Microbiol 138(Pt 8):1717\u20131727","journal-title":"J Gen Microbiol"},{"issue":"2","key":"1_CR124","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1164\/rccm.202006-2394","volume":"203","author":"EA Kendall","year":"2021","unstructured":"Kendall EA, Shrestha S, Dowdy DW (2021) The epidemiological importance of subclinical tuberculosis. A critical reappraisal. Am J Respir Crit Care Med 203(2):168\u2013174. https:\/\/doi.org\/10.1164\/rccm.202006-2394","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1_CR125","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMra1205429","volume":"367","author":"S Keshavjee","year":"2012","unstructured":"Keshavjee S, Farmer PE (2012) Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med 367(10):931\u2013936","journal-title":"N Engl J Med"},{"key":"1_CR126","first-page":"221","volume":"19","author":"R Koch","year":"1882","unstructured":"Koch R (1882) The etiology of tuberculosis. Berliner Klinische Wochenschrift 19:221\u2013230","journal-title":"Berliner Klinische Wochenschrift"},{"key":"1_CR1004","unstructured":"Koch EK (1932) The diary of Elsie Kleiner Koch. Paperback ed. English. ISBN: 9780615242774"},{"key":"1_CR1006","doi-asserted-by":"crossref","unstructured":"Koura KG, Harries AD (2024) The trend of tuberculosis case notification rates from 1995 to 2022 by country income and World Health Organization region. Trop Med Infect Dis 9(12):294. https:\/\/doi.org\/10.3390\/tropicalmed9120294. PMID: 39728821; PMCID: PMC11679434","DOI":"10.3390\/tropicalmed9120294"},{"issue":"4","key":"1_CR127","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<423::AID-AJIM16>3.0.CO;2-5","volume":"32","author":"K Kreiss","year":"1997","unstructured":"Kreiss K, Cox-Ganser J (1997) Metalworking fluid-associated hypersensitivity pneumonitis: a workshop summary. Am J Ind Med 32(4):423\u2013432","journal-title":"Am J Ind Med"},{"key":"1_CR128","volume":"2014","author":"L Krishnan","year":"2014","unstructured":"Krishnan L, Akande T, Shankar AV, McIntire KN, Gounder CR, Gupta A, Yang WT (2014) Gender-related barriers and delays in accessing tuberculosis diagnostic and treatment services: a systematic review of qualitative studies. Tuberc Res Treat. 2014:215059","journal-title":"Tuberc Res Treat."},{"key":"1_CR129","doi-asserted-by":"publisher","first-page":"103053","DOI":"10.1016\/j.ebiom.2020.103053","volume":"61","author":"EE Kroon","year":"2020","unstructured":"Kroon EE, Kinnear CJ, Orlova M, Fischinger S, Shin S, Boolay S, Walzl G, Jacobs A, Wilkinson RJ, Alter G, Schurr E, Hoal EG, M\u00f6ller M (2020) An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa. EBioMedicine 61:103053","journal-title":"EBioMedicine"},{"issue":"9","key":"1_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222937","volume":"14","author":"CC Ku","year":"2019","unstructured":"Ku CC, Dodd PJ (2019) Forecasting the impact of population ageing on tuberculosis incidence. PLoS One 14(9):e0222937","journal-title":"PLoS One"},{"issue":"13","key":"1_CR131","doi-asserted-by":"publisher","first-page":"1576875","DOI":"10.3389\/fpubh.2025.1576875","volume":"29","author":"A Kumah","year":"2025","unstructured":"Kumah A (2025 May) Building community networks and engagement for effective TB case management. Front Public Health 29(13):1576875","journal-title":"Front Public Health"},{"issue":"2","key":"1_CR132","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.idc.2016.02.010","volume":"30","author":"SG Kurz","year":"2016","unstructured":"Kurz SG, Furin JJ, Bark CM (2016) Drug-resistant tuberculosis: challenges and Progress. Infect Dis Clin N Am 30(2):509\u2013522","journal-title":"Infect Dis Clin N Am"},{"issue":"1","key":"1_CR134","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Aaby P, Behr MA, Donald PR, Kaufmann SHE, Netea MG, Mandalakas AM (2022) 100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin. Lancet Infect Dis 22(1):e2\u2013e12","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1_CR135","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(13)70008-2","volume":"13","author":"SD Lawn","year":"2013","unstructured":"Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A (2013) Advances in tuberculosis diagnostics: the Xpert MTB\/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13(4):349\u2013361","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1_CR136","first-page":"148","volume":"6","author":"KM Laycock","year":"2021","unstructured":"Laycock KM, Enane LA, Steenhoff AP (2021) Tuberculosis in adolescents and young adults: emerging data on TB transmission and prevention among vulnerable young people. Trop Med Infect Dis 6(3):148","journal-title":"Trop Med Infect Dis"},{"issue":"7","key":"1_CR137","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(24)00007-0","volume":"24","author":"JR Ledesma","year":"2024","unstructured":"Ledesma JR, Castillo M, Reyes A et al (2024) Tuberculosis collaborators. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO end TB strategy: a systematic analysis for the global burden of disease study 2021. Lancet Infect Dis 24(7):698\u2013725","journal-title":"Lancet Infect Dis"},{"issue":"16","key":"1_CR138","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","volume":"367","author":"M Lee","year":"2012","unstructured":"Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE 3rd. (2012) Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 367(16):1508\u20131518","journal-title":"N Engl J Med"},{"key":"1_CR139","doi-asserted-by":"publisher","DOI":"10.2196\/49741","volume":"11","author":"S Lee","year":"2023","unstructured":"Lee S, Rajaguru V, Baek JS, Shin J, Park Y (2023) Digital health interventions to enhance tuberculosis treatment adherence: scoping review. JMIR Mhealth Uhealth 11:e49741","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6384","key":"1_CR140","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(46)91185-3","volume":"1","author":"J Lehmann","year":"1946","unstructured":"Lehmann J (1946) Para-aminosalicylic acid in the treatment of tuberculosis. Lancet 1(6384):15","journal-title":"Lancet"},{"issue":"1","key":"1_CR141","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12889-023-15553-7","volume":"23","author":"Y Lei","year":"2023","unstructured":"Lei Y, Wang J, Wang Y, Xu C (2023) Geographical evolutionary pathway of global tuberculosis incidence trends. BMC Public Health 23(1):755","journal-title":"BMC Public Health"},{"issue":"7","key":"1_CR142","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.arbres.2019.11.015","volume":"56","author":"E Letang","year":"2020","unstructured":"Letang E, Ellis J, Naidoo K, Casas EC, S\u00e1nchez P, Hassan-Moosa R, Cresswell F, Mir\u00f3 JM, Garc\u00eda-Basteiro AL (2020) Tuberculosis-HIV co-infection: Progress and challenges after two decades of global antiretroviral treatment roll-out. Arch Bronconeumol 56(7):446\u2013454","journal-title":"Arch Bronconeumol"},{"issue":"9","key":"1_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.935080","volume":"28","author":"S Liang","year":"2022","unstructured":"Liang S, Ma J, Wang G, Shao J, Li J, Deng H, Wang C, Li W (2022 Jul) The application of artificial intelligence in the diagnosis and drug resistance prediction of pulmonary tuberculosis. Front Med 28(9):935080","journal-title":"Front Med"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0044-8486(98)00187-2","volume":"164","author":"DV Lightner","year":"1998","unstructured":"Lightner DV, Redman RM (1998) ACUaCUltUre. Aquaculture 164:201\u2013203","journal-title":"Aquaculture"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3201\/eid0807.010482","volume":"8","author":"T Lillebaek","year":"2002","unstructured":"Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A (2002) Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis 8:679\u2013684","journal-title":"Emerg Infect Dis"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2022.06.020","volume":"533","author":"M Lin","year":"2022","unstructured":"Lin M, Chen YW, Li YR, Long LJ, Qi LY, Cui TT, Wu SY, Lin JY, Wu T, Yang YC, Yuan WH, Wu GY, Lan QW, Liu JQ, Li YP, Yu ZY, Guo XG (2022) Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis. Clin Chim Acta 533:183\u2013218","journal-title":"Clin Chim Acta"},{"key":"1_CR148","doi-asserted-by":"crossref","unstructured":"Lone MY, Kumar SP, Athar M, Jha PC (2018) Exploration of Mycobacterium tuberculosis structural proteome: an in-silico approach. J Theoret Biol 439, 14:\u201323","DOI":"10.1016\/j.jtbi.2017.11.021"},{"issue":"3","key":"1_CR149","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/trstmh\/trv108","volume":"110","author":"K L\u00f6nnroth","year":"2016","unstructured":"L\u00f6nnroth K, Raviglione M (2016) The WHO\u2019S new end TB strategy in the post-2015 era of the sustainable development goals. Trans R Soc Trop Med Hyg 110(3):148\u2013150","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1_CR1016","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Roa P, Martin-Higuera C, Ruiz-Serrano MJ, Toro C, Tato M, Simon M et al (2021) Performance of Xpert MTB\/RIF ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence. Diagn Microbiol Infect Dis 99(2):115235. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115235","DOI":"10.1016\/j.diagmicrobio.2020.115235"},{"key":"1_CR1013","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Medrano F, Carver PL, Rutjanawech S, Aranha-Camargo LF, Fernandes R, Belga S, Daniels SA, Mueller NJ, Burkhard S, Theodoropoulos NM, Postma DF (2025) Clinical management and outcomes of nontuberculous mycobacterial infections in solid organ transplant recipients: a multinational case-control study. Transplantation 109(2):e134\u2013e141","DOI":"10.1097\/TP.0000000000005156"},{"key":"1_CR150","first-page":"889","volume-title":"The prokaryotes","author":"S Lory","year":"2014","unstructured":"Lory S (2014) The Family Mycobacteriaceae. In: Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F (eds) The prokaryotes. Springer, Berlin\/Heidelberg, pp 889\u2013918"},{"issue":"3","key":"1_CR151","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/molecules25030665","volume":"25","author":"SJ Macalino","year":"2020","unstructured":"Macalino SJ, Billones J, Organo V, Carrillo MC (2020) In Silico strategies in tuberculosis drug discovery. Molecules 25(3):665","journal-title":"Molecules"},{"issue":"11","key":"1_CR152","doi-asserted-by":"publisher","first-page":"281","DOI":"10.15585\/mmwr.mm6911a2","volume":"69","author":"A MacNeil","year":"2020","unstructured":"MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K (2020) Global epidemiology of tuberculosis and Progress toward meeting global targets \u2013 worldwide, 2018. MMWR Morb Mortal Wkly Rep 69(11):281\u2013285","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1_CR153","first-page":"451","volume":"18","author":"AS Madaki","year":"2024","unstructured":"Madaki AS, Ahmad K, Singh D (2024) IT integration implementation in e-government public sector in developing countries: a systematic literature review and model development. Transform Govern People Process Policy 18(3):451\u2013472","journal-title":"Transform Govern People Process Policy"},{"key":"1_CR154","first-page":"312","volume-title":"Bergey\u2019s manual of systematic bacteriology: volume 5: the Actinobacteria","author":"JG Magee","year":"2012","unstructured":"Magee JG, Ward AC, Family III (2012) Mycobacteriaceae Chester 1897, 63AL. In: Bergey\u2019s manual of systematic bacteriology: volume 5: the Actinobacteria. Springer, New York, p 312"},{"issue":"7","key":"1_CR155","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/1744666X.2024.2326032","volume":"20","author":"S Mahmoudi","year":"2024","unstructured":"Mahmoudi S, Garc\u00eda MJ, Drain PK (2024) Current approaches for diagnosis of subclinical pulmonary tuberculosis, clinical implications and future perspectives: a scoping review. Expert Rev Clin Immunol 20(7):715\u2013726","journal-title":"Expert Rev Clin Immunol"},{"key":"1_CR156","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41043-025-00788-4","volume":"44","author":"E Malla","year":"2025","unstructured":"Malla E, Shahi S, Forsberg B (2025) Barriers and facilitators to tuberculosis service access for patients in Bajhang, Nepal: a qualitative study based on focus groups with patients, screening camp visitors, community volunteers and medical doctors. J Health Popul Nutr 44:46","journal-title":"J Health Popul Nutr"},{"issue":"9","key":"1_CR157","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/microorganisms11092277","volume":"11","author":"G Mancuso","year":"2023","unstructured":"Mancuso G, Midiri A, De Gaetano S, Ponzo E, Biondo C (2023) Tackling drug-resistant tuberculosis: new challenges from the old pathogen Mycobacterium tuberculosis. Microorganisms 11(9):2277","journal-title":"Microorganisms"},{"issue":"9","key":"1_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103052","volume":"24","author":"J Mao","year":"2021","unstructured":"Mao J, Akhtar J, Zhang X, Sun L, Guan S, Li X, Chen G, Liu J, Jeon HN, Kim MS, No KT, Wang G (2021) Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models. iScience 24(9):103052","journal-title":"iScience"},{"issue":"1","key":"1_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227293","volume":"15","author":"SB Marahatta","year":"2020","unstructured":"Marahatta SB, Yadav RK, Giri D, Lama S, Rijal KR, Mishra SR, Shrestha A, Bhattrai PR, Mahato RK, Adhikari B (2020) Barriers in the access, diagnosis and treatment completion for tuberculosis patients in central and western Nepal: a qualitative study among patients, community members and health care workers. PLoS One 15(1):e0227293","journal-title":"PLoS One"},{"issue":"3","key":"1_CR161","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijtb.2016.08.007","volume":"63","author":"P Marimuthu","year":"2016","unstructured":"Marimuthu P (2016) Tuberculosis prevalence and socio-economic differentials in the slums of four metropolitan cities of India. Indian J Tuberc 63(3):167\u2013170","journal-title":"Indian J Tuberc"},{"key":"1_CR162","doi-asserted-by":"crossref","unstructured":"Mase SR, Chorba T (2019) Treatment of drug-resistant tuberculosis. Clin Chest Med 40(4):775\u2013795. https:\/\/doi.org\/10.1016\/j.ccm.2019.08.002. PMID: 31731984; PMCID: PMC7000172","DOI":"10.1016\/j.ccm.2019.08.002"},{"key":"1_CR1015","doi-asserted-by":"crossref","unstructured":"Maseko AF, Silumbwe A, Maritim P, Munakampe MN, Chirambo GB, Jacobs C, Zulu JM (2025) Factors that shape the integration of HIV and TB services in Zomba District, Malawi. BMC Health Serv Res 25(1):213. https:\/\/doi.org\/10.1186\/s12913-025-12367-8. PMID: 39915793; PMCID: PMC11800521","DOI":"10.1186\/s12913-025-12367-8"},{"issue":"7","key":"1_CR163","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1086\/507542","volume":"43","author":"MR Masjedi","year":"2006","unstructured":"Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, Akbarvelayati A, Hoffner S (2006) Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 43(7):841\u2013847","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1_CR164","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/014107680109400813","volume":"94","author":"OR McCarthy","year":"2001","unstructured":"McCarthy OR (2001) The key to the sanatoria. J R Soc Med 94(8):413\u2013417","journal-title":"J R Soc Med"},{"issue":"3","key":"1_CR165","doi-asserted-by":"publisher","first-page":"240056","DOI":"10.1183\/20734735.0056-2024","volume":"20","author":"M McClean","year":"2024","unstructured":"McClean M, Panciu TC, Lange C, Duarte R, Theis F (2024) Artificial intelligence in tuberculosis: a new ally in disease control. Breathe 20(3):240056","journal-title":"Breathe"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s44263-025-00166-6","volume":"3","author":"A Medina-Marino","year":"2025","unstructured":"Medina-Marino A, de Vos L, Daniels J (2025) Social isolation, social exclusion, and access to mental and tangible resources: mapping the gendered impact of tuberculosis-related stigma among men and women living with tuberculosis in Eastern Cape Province. South Africa BMC Glob Public Health 3:50","journal-title":"South Africa BMC Glob Public Health"},{"issue":"3","key":"1_CR167","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tim.2009.12.007","volume":"18","author":"H Medjahed","year":"2010","unstructured":"Medjahed H, Gaillard JL, Reyrat JM (2010) Mycobacterium abscessus: a new player in the mycobacterial field. Trends Microbiol 18(3):117\u2013123","journal-title":"Trends Microbiol"},{"issue":"2","key":"1_CR168","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7(2):146\u2013157","journal-title":"Curr Comput Aided Drug Des"},{"issue":"1","key":"1_CR169","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1038\/s41467-023-41937-9","volume":"14","author":"NA Menzies","year":"2023","unstructured":"Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP, Knight GM, Meghji J, Nguyen LN, Rachow A, Schumacher SG, Mirzayev F, Cohen T (2023) Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nat Commun 14(1):6182","journal-title":"Nat Commun"},{"issue":"5","key":"1_CR170","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3201\/eid1305.060200","volume":"13","author":"GB Migliori","year":"2007","unstructured":"Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, Cirillo DM, Ferrarese M, De Iaco G, Gori A, Raviglione MC, SMIRA\/TBNET Study Group (2007) Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 13(5):780\u2013782","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"1_CR171","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1183\/09031936.00028708","volume":"31","author":"GB Migliori","year":"2008","unstructured":"Migliori GB, Lange C, Centis R, Sotgiu G, M\u00fctterlein R, Hoffmann H, Kliiman K, De Iaco G, Lauria FN, Richardson MD, Spanevello A, Cirillo DM, TBNET Study Group (2008) Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J 31(6):1155\u20131159","journal-title":"Eur Respir J"},{"issue":"3","key":"1_CR172","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0079-2021","volume":"17","author":"GB Migliori","year":"2021","unstructured":"Migliori GB, Ong CWM, Petrone L, D\u2019Ambrosio L, Centis R, Goletti D (2021) The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe (Sheff) 17(3):210079","journal-title":"Breathe (Sheff)"},{"issue":"9","key":"1_CR174","first-page":"796","volume":"4","author":"DA Mitchison","year":"2000","unstructured":"Mitchison DA (2000) Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 4(9):796\u2013806. Erratum in: Int J Tuberc Lung Dis. 2003 7(3):304. PMID: 10985648","journal-title":"Int J Tuberc Lung Dis"},{"key":"1_CR175","doi-asserted-by":"publisher","first-page":"1446930","DOI":"10.3389\/fvets.2024.1446930","volume":"11","author":"C Moens","year":"2024","unstructured":"Moens C, Bogaerts B, Lorente-Leal V, Vanneste K, De Keersmaecker SCJ, Roosens NHC, Mostin L, Fretin D, March\u00e9 S (2024) Genomic comparison between Mycobacterium bovis and Mycobacterium microti and in silico analysis of peptide-based biomarkers for serodiagnosis. Front Vet Sci 11:1446930","journal-title":"Front Vet Sci"},{"issue":"23","key":"1_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25122","volume":"38","author":"N Mohammadnabi","year":"2024","unstructured":"Mohammadnabi N, Shamseddin J, Emadi M, Bodaghi AB, Varseh M, Shariati A, Rezaei M, Dastranj M, Farahani A (2024) Mycobacterium tuberculosis: The mechanism of pathogenicity, immune responses, and diagnostic challenges. J Clin Lab Anal 38(23):e25122","journal-title":"J Clin Lab Anal"},{"key":"1_CR1005","doi-asserted-by":"crossref","unstructured":"Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS et al (2018) Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India. BMJ Glob Health 3(5):e001135. https:\/\/doi.org\/10.1136\/bmjgh-2018-001135. PMID: 30364389; PMCID: PMC6195150","DOI":"10.1136\/bmjgh-2018-001135"},{"key":"1_CR177","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1038\/s41598-025-86079-8","volume":"15","author":"G Morey-Le\u00f3n","year":"2025","unstructured":"Morey-Le\u00f3n G, Mej\u00eda-Ponce PM, Fern\u00e1ndez-Cadena JC, Garc\u00eda-Moreira E, Andrade-Molina D, Licona-Cassani C, Fresia P, Bern\u00e1 L (2025) Global epidemiology of Mycobacterium tuberculosis lineage 4 insights from Ecuadorian genomic data. Sci Rep 15:3823","journal-title":"Sci Rep"},{"key":"1_CR178","first-page":"524","volume":"90","author":"D Morse","year":"1964","unstructured":"Morse D, Brothwell DR, Ucko PJ (1964) Tuberculosis in ancient Egypt. Am Rev Respir Dis 90:524\u2013541","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"1_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.102649","volume":"18","author":"SMA Mousavi-Sagharchi","year":"2025","unstructured":"Mousavi-Sagharchi SMA, Ghorbani A, Meskini M, Siadat SD (2025) Historical examination of tuberculosis: from ancient affliction to modern challenges. J Infect Public Health 18(3):102649","journal-title":"J Infect Public Health"},{"issue":"1","key":"1_CR180","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/ijmy.ijmy_19_24","volume":"13","author":"H Muflihah","year":"2024","unstructured":"Muflihah H, Yulianto FA, Rina SE, Ferdiana A, Rahimah SB (2024) Tuberculosis coinfection among COVID-19 patients: clinical presentation and mortality in a tertiary lung Hospital in Indonesia. Int J Mycobacteriol. 13(1):58\u201364","journal-title":"Int J Mycobacteriol."},{"key":"1_CR181","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1570180819666220922103109","volume":"21","author":"MT Muhammed","year":"2024","unstructured":"Muhammed MT, Aki-Yalcin E (2024) Molecular docking: principles, advances, and its applications in drug discovery. Lett Drug Des Discov 21:480\u2013495","journal-title":"Lett Drug Des Discov"},{"issue":"4","key":"1_CR182","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S2213-2600(23)00090-5","volume":"11","author":"K Naidoo","year":"2023","unstructured":"Naidoo K, Perumal R (2023) Advances in tuberculosis control during the past decade. Lancet Respir Med 11(4):311\u2013313","journal-title":"Lancet Respir Med"},{"key":"1_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2019.100122","volume":"17","author":"K Naidoo","year":"2019","unstructured":"Naidoo K, Gengiah S, Singh S, Stillo J, Padayatchi N (2019) Quality of TB care among people living with HIV: gaps and solutions. J Clin Tubercul Other Mycobacter Dis 17:100122","journal-title":"J Clin Tubercul Other Mycobacter Dis"},{"key":"1_CR184","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12939-025-02437-y","volume":"24","author":"T Nalugwa","year":"2025","unstructured":"Nalugwa T, Annerstedt KS, Nabwire S, West NS, Kadota JL, Atkins S, Cattamanchi A, L\u00f6nnroth K, Katamba A, Shete PB (2025) Identifying mechanisms by which social determinants of health impact TB diagnostic evaluation uptake in Uganda: a qualitative study. Int J Equity Health 24:73","journal-title":"Int J Equity Health"},{"issue":"15","key":"1_CR185","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.2147\/IDR.S381643","volume":"29","author":"L Nandlal","year":"2022","unstructured":"Nandlal L, Perumal R, Naidoo K (2022) Rapid molecular assays for the diagnosis of drug-resistant tuberculosis. Infect Drug Resist 29(15):4971\u20134984","journal-title":"Infect Drug Resist"},{"key":"1_CR186","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/828939","volume":"2013","author":"P Narasimhan","year":"2013","unstructured":"Narasimhan P, Wood J, Macintyre CR, Mathai D (2013) Risk factors for tuberculosis. Pulm Med 2013:828939","journal-title":"Pulm Med"},{"key":"1_CR187","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijid.2014.11.018","volume":"32","author":"J Negin","year":"2015","unstructured":"Negin J, Abimbola S, Marais BJ (2015) Tuberculosis among older adults--time to take notice. Int J Infect Dis 32:135\u2013137","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1_CR188","doi-asserted-by":"publisher","first-page":"1701596","DOI":"10.1183\/13993003.01596-2017","volume":"51","author":"BK Ngwatu","year":"2018","unstructured":"Ngwatu BK, Nsengiyumva NP, Oxlade O, Mappin-Kasirer B, Nguyen NL, Jaramillo E, Falzon D, Schwartzman K (2018) Collaborative group on the impact of digital technologies on TB. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur Respir J 51(1):1701596","journal-title":"Eur Respir J"},{"key":"1_CR189","doi-asserted-by":"crossref","unstructured":"Nhamoyebonde S, Leslie A (2014) Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis (209, Suppl 3):S100\u2013S106","DOI":"10.1093\/infdis\/jiu147"},{"issue":"12","key":"1_CR190","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021188","volume":"4","author":"S Niemann","year":"2014","unstructured":"Niemann S, Supply P (2014) Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches. Cold Spring Harb Perspect Med 4(12):a021188","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"1_CR191","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1128\/JCM.42.9.3958-3962.2004","volume":"42","author":"S Niemann","year":"2004","unstructured":"Niemann S, Kubica T, Bange FC, Adjei O, Browne EN, Chinbuah MA, Diel R, Gyapong J, Horstmann RD, Joloba ML, Meyer CG, Mugerwa RD, Okwera A, Osei I, Owusu-Darbo E, Schwander SK, R\u00fcsch-Gerdes S (2004) The species Mycobacterium africanum in the light of new molecular markers. J Clin Microbiol 42(9):3958\u20133962","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1_CR192","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MCP.0000000000001070","volume":"30","author":"PS Nyasulu","year":"2024","unstructured":"Nyasulu PS, Doumbia CO, Ngah V, Togo ACG, Diarra B, Chongwe G (2024) Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management. Curr Opin Pulm Med 30(3):217\u2013228","journal-title":"Curr Opin Pulm Med"},{"key":"1_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.insi.2025.100012","volume":"1","author":"TA Nyijime","year":"2025","unstructured":"Nyijime TA, Shallangwa GA, Uzairu A, Umar AB, Ibrahim MT, Madkhali HA et al (2025) Computational design, pharmacokinetics, molecular docking and molecular dynamic simulation of novel anti-tubercular inhibitors. In Silico Res Biomed 1:100012","journal-title":"In Silico Res Biomed"},{"issue":"11","key":"1_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1700","volume":"6","author":"EI Obeagu","year":"2023","unstructured":"Obeagu EI (2023) Tuberculosis diagnostic and treatment delays among patients in Uganda. Health Sci Rep. 6(11):e1700","journal-title":"Health Sci Rep."},{"issue":"1","key":"1_CR195","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12939-020-01342-w","volume":"19","author":"C Oga-Omenka","year":"2020","unstructured":"Oga-Omenka C, Bada F, Agbaje A, Dakum P, Menzies D, Zarowsky C (2020) Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes. Int J Equity Health 19(1):221","journal-title":"Int J Equity Health"},{"key":"1_CR196","doi-asserted-by":"publisher","DOI":"10.2196\/40311","volume":"9","author":"C Ogbudebe","year":"2023","unstructured":"Ogbudebe C, Jeong D, Odume B, Chukwuogo O, Dim C, Useni S, Okuzu O, Malolan C, Kim D, Nwariaku F, Nwokoye N, Gande S, Nongo D, Eneogu R, Odusote T, Oyelaran S, ChijiokeAkaniro O, Nihalani N, Anyaike C, Gidado M (2023) Identifying hot spots of tuberculosis in Nigeria using an early warning outbreak recognition system: retrospective analysis of implications for active casefinding interventions. JMIR Public Health Surveill 9:e40311","journal-title":"JMIR Public Health Surveill"},{"key":"1_CR197","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-016820","volume":"9","author":"TJ Ogunniyi","year":"2024","unstructured":"Ogunniyi TJ, Abdulganiyu MO, Issa JB et al (2024) Ending tuberculosis in Nigeria: a priority by 2030. BMJ Glob Health 9:e016820","journal-title":"BMJ Glob Health"},{"issue":"2","key":"1_CR198","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4314\/ahs.v23i2.16","volume":"23","author":"SA Olaleye","year":"2023","unstructured":"Olaleye SA, Balogun OS, Adusei-Mensah F (2023) Bibliometric structured review of tuberculosis in Nigeria. Afr Health Sci 23(2):139\u2013160","journal-title":"Afr Health Sci"},{"key":"1_CR199","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s42399-023-01568-z","volume":"5","author":"C Olivier","year":"2023","unstructured":"Olivier C, Luies L (2023) WHO goals and beyond: managing HIV\/TB co-infection in South Africa. SN Compr Clin Med 5:251","journal-title":"SN Compr Clin Med"},{"issue":"10","key":"1_CR200","first-page":"1101","volume":"11","author":"AM Olmo-Font\u00e1nez","year":"2022","unstructured":"Olmo-Font\u00e1nez AM, Turner J (2022) Tuberculosis in an aging world Pathogens 11(10):1101","journal-title":"Tuberculosis in an aging world Pathogens"},{"key":"1_CR201","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/1471-2458-10-381","volume":"10","author":"DA Onifade","year":"2010","unstructured":"Onifade DA, Bayer AM, Montoya R, Haro M, Alva J, Franco J, Sosa R, Valiente B, Valera E, Ford CM, Acosta CD, Evans CA (2010) Gender-related factors influencing tuberculosis control in shantytowns: a qualitative study. BMC Public Health 10:381","journal-title":"BMC Public Health"},{"issue":"2","key":"1_CR202","doi-asserted-by":"publisher","first-page":"fuae006","DOI":"10.1093\/femsre\/fuae006","volume":"48","author":"M Orgeur","year":"2024","unstructured":"Orgeur M, Sous C, Madacki J, Brosch R (2024) Evolution and emergence of Mycobacterium tuberculosis. FEMS Microbiol Rev 48(2):fuae006","journal-title":"FEMS Microbiol Rev"},{"key":"1_CR203","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fimmu.2019.01076","volume":"10","author":"E Ortona","year":"2019","unstructured":"Ortona E, Pierdominici M, Rider V (2019) Editorial: sex hormones and gender differences in immune responses. Front Immunol 10:1076","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"1_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100594","volume":"14","author":"S Osei-Wusu","year":"2025","unstructured":"Osei-Wusu S, Asare P, Danso EK, Asogun D, Otchere ID, Asante-Poku A, Yeboah-Manu D (2025a) Addressing key risk factors hindering tuberculosis control activities in West Africa \u2013 progress in meeting the UN sustainable development goals. IJID Reg. 14(Suppl 2):100594","journal-title":"IJID Reg."},{"key":"1_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2025.100594","volume":"14","author":"S Osei-Wusu","year":"2025","unstructured":"Osei-Wusu S, Asare P, Danso EK, Asogun D, Otchere ID, Asante-Poku A, Yeboah-Manu D (2025b) Addressing key risk factors hindering tuberculosis control activities in West Africa-progress in meeting the UN sustainable development goals. IJID Regions 14:100594","journal-title":"IJID Regions"},{"issue":"4","key":"1_CR206","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/ijmy.ijmy_191_24","volume":"13","author":"DC Oshi","year":"2024","unstructured":"Oshi DC, Amah PO, Alobu IN, Oshi SN, Brown S, Ukwaja KN (2024) Enhancing knowledge and beliefs: the impact of a gender-transformative training program on tuberculosis care in southern Nigeria. Int J Mycobacteriol. 13(4):394\u2013403","journal-title":"Int J Mycobacteriol."},{"issue":"17","key":"1_CR208","doi-asserted-by":"publisher","first-page":"2400211","DOI":"10.2807\/1560-7917.ES.2024.29.17.2400211","volume":"29","author":"R Otto-Knapp","year":"2024","unstructured":"Otto-Knapp R, Edwards S, Kuchukhidze G, Kr\u00f6ger S, H\u00e4cker B, Bivol S, Yedilbayev A (2024) Availability of drugs for the treatment of multidrug-resistant\/rifampicin-resistant tuberculosis in the World Health Organization European region, October 2023. Euro Surveill 29(17):2400211","journal-title":"Euro Surveill"},{"key":"1_CR209","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJMp2118145","volume":"386","author":"M Pai","year":"2022","unstructured":"Pai M, Kasaeva T, Swaminathan S (2022) Covid-19\u2019s devastating effect on tuberculosis care \u2013 a path to recovery. N Engl J Med 386:1490","journal-title":"N Engl J Med"},{"key":"1_CR210","first-page":"145","volume":"97","author":"CN Paramasivan","year":"1993","unstructured":"Paramasivan CN, Herbert D, Prabhakar R (1993) Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro. Indian J Med Res 97:145\u2013150. PMID: 8406638","journal-title":"Indian J Med Res"},{"issue":"4","key":"1_CR211","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/joim.12264","volume":"277","author":"SK Parida","year":"2015","unstructured":"Parida SK, Axelsson-Robertson R, Rao MV, Singh N, Master I, Lutckii A, Keshavjee S, Andersson J, Zumla A, Maeurer M (2015) Totally drug-resistant tuberculosis and adjunct therapies. J Intern Med 277(4):388\u2013405","journal-title":"J Intern Med"},{"issue":"3","key":"1_CR212","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","volume":"6","author":"NM Parrish","year":"1998","unstructured":"Parrish NM, Dick JD, Bishai WR (1998) Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 6(3):107\u2013112","journal-title":"Trends Microbiol"},{"issue":"11","key":"1_CR213","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1099\/ijsem.0.004332","volume":"70","author":"AC Parte","year":"2020","unstructured":"Parte AC, Sard\u00e0 Carbasse J, Meier-Kolthoff JP, Reimer LC, G\u00f6ker M (2020) List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol 70(11):5607\u20135612","journal-title":"Int J Syst Evol Microbiol"},{"key":"1_CR215","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.biopha.2018.01.115","volume":"99","author":"K Patil","year":"2018","unstructured":"Patil K, Bagade S, Bonde S, Sharma S, Saraogi G (2018) Recent therapeutic approaches for the management of tuberculosis: challenges and opportunities. Biomed Pharmacother 99:735\u2013745","journal-title":"Biomed Pharmacother"},{"key":"1_CR1017","doi-asserted-by":"crossref","unstructured":"Patil TS, Nirbhavane P, Aher AA, Gujarathi NA, Khairnar TD, Goyal YS (2025) Future prospects and clinical aspects for the management of tuberculosis. In: Emerging paradigms in delivery Systems for Antitubercular Therapy. Academic Press, pp 371\u2013395","DOI":"10.1016\/B978-0-443-24035-5.00017-7"},{"issue":"3","key":"1_CR217","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3201\/eid3103.241272","volume":"31","author":"R Paul","year":"2025","unstructured":"Paul R, Lorenzo F, L\u00f3pez B, Alegre MG, Couvin D, Rastogi N, P\u00e9rez-Lago L, Garc\u00eda de Viedma D, Gamberale A, Gonz\u00e1lez N, Palmero D, Altabe S, Simboli N, Yokobori NK (2025) Outbreak caused by multidrug-resistant Mycobacterium tuberculosis with unusual combination of resistance mutations, northern Argentina, 2006\u20132022. Emerg Infect Dis 31(3):601\u2013606","journal-title":"Emerg Infect Dis"},{"key":"1_CR218","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.997025","volume":"10","author":"V Peer","year":"2023","unstructured":"Peer V, Schwartz N, Green MS (2023) Gender differences in tuberculosis incidence rates\u2014a pooled analysis of data from seven high-income countries by age group and time period. Front Public Health 10:997025","journal-title":"Front Public Health"},{"issue":"4","key":"1_CR219","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3201\/eid0404.980414","volume":"4","author":"GE Pfyffer","year":"1998","unstructured":"Pfyffer GE, Auckenthaler R, van Embden JD, van Soolingen D (1998) Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerg Infect Dis 4(4):631\u2013634","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"1_CR221","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1128\/jcm.35.5.1097-1100.1997","volume":"35","author":"F Portaels","year":"1997","unstructured":"Portaels F, Aguiar J, Fissette K, Fonteyne PA, De Beenhouwer H, De Rijk P et al (1997) Direct detection and identification of mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 35(5):1097\u20131100","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1_CR222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004252","volume":"20","author":"A Portnoy","year":"2023","unstructured":"Portnoy A, Arcand JL, Clark RA, Weerasuriya CK, Mukandavire C, Bakker R, Patouillard E, Gebreselassie N, Zignol M, Jit M, White RG, Menzies NA (2023) The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: a modeling study. PLoS Med 20(7):e1004252","journal-title":"PLoS Med"},{"issue":"6","key":"1_CR223","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","volume":"77","author":"IS Pradipta","year":"2018","unstructured":"Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW (2018) Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J Infect 77(6):469\u2013478","journal-title":"J Infect"},{"issue":"12","key":"1_CR224","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1586\/14787210.2014.974560","volume":"12","author":"WM Prodinger","year":"2014","unstructured":"Prodinger WM, Indra A, Koksalan OK, Kilicaslan Z, Richter E (2014) Mycobacterium caprae infection in humans. Expert Rev Anti-Infect Ther 12(12):1501\u20131513","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"9","key":"1_CR225","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/S2589-7500(21)00116-3","volume":"3","author":"ZZ Qin","year":"2021","unstructured":"Qin ZZ, Ahmed S, Sarker MS, Paul K, Adel ASS, Naheyan T, Barrett R, Banu S, Creswell J (2021) Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms. Lancet Digit Health 3(9):e543\u2013e554","journal-title":"Lancet Digit Health"},{"issue":"3","key":"1_CR226","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1515\/dx-2018-0036","volume":"6","author":"M Quinn","year":"2019","unstructured":"Quinn M, Forman J, Harrod M, Winter S, Fowler KE, Krein SL, Gupta A, Saint S, Singh H, Chopra V (2019) Electronic health records, communication, and data sharing: challenges and opportunities for improving the diagnostic process. Diagnosis (Berl) 6(3):241\u2013248","journal-title":"Diagnosis (Berl)"},{"issue":"3","key":"1_CR227","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/ijmy.ijmy_141_21","volume":"10","author":"P Rajendran","year":"2021","unstructured":"Rajendran P, Padmapriyadarsini C, Mondal R (2021) Nontuberculous mycobacterium: An emerging pathogen: Indian perspective. Int J Mycobacteriol. 10(3):217\u2013227","journal-title":"Int J Mycobacteriol."},{"issue":"1","key":"1_CR228","doi-asserted-by":"publisher","first-page":"21","DOI":"10.20506\/rst.20.1.1265","volume":"20","author":"N Rastogi","year":"2001","unstructured":"Rastogi N, Legrand E, Sola C (2001) The mycobacteria: an introduction to nomenclature and pathogenesis. Revue Scientifique Et Technique-Office International Des Epizooties 20(1):21\u201354","journal-title":"Revue Scientifique Et Technique-Office International Des Epizooties"},{"issue":"4","key":"1_CR229","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/0963721417700691","volume":"26","author":"R Ratwani","year":"2017","unstructured":"Ratwani R (2017) Electronic health records and improved patient care: opportunities for applied psychology. Curr Dir Psychol Sci 26(4):359\u2013365","journal-title":"Curr Dir Psychol Sci"},{"key":"1_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102388","volume":"16","author":"ZU Rehman","year":"2025","unstructured":"Rehman ZU, Alhazmi HA, Albratty M, Algaissi A, Makeen HA, Najmi A et al (2025) Structural insights into PKS13 Thioesterase inhibitors targeting Mycobacterium tuberculosis for drug-resistant tuberculosis therapy: identification, stability assessment, and pharmacophore modeling. Results Chem 16:102388","journal-title":"Results Chem"},{"issue":"10","key":"1_CR231","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.21037\/jtd.2016.10.14","volume":"8","author":"A Rendon","year":"2016","unstructured":"Rendon A, Tiberi S, Scardigli A, D\u2019Ambrosio L, Centis R, Caminero JA, Migliori GB (2016) Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives. J Thorac Dis 8(10):2666\u20132671","journal-title":"J Thorac Dis"},{"key":"1_CR232","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbi.2006.06.005","volume":"21","author":"AD Rey","year":"2017","unstructured":"Rey AD, Mahuad CV, Bozza VV, Bogue C, Farroni MA, Bay ML, Bottasso OA, Besedovsky HO (2017) Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun 21:171\u2013179","journal-title":"Brain Behav Immun"},{"issue":"3","key":"1_CR233","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1086\/514084","volume":"176","author":"V Ritacco","year":"1997","unstructured":"Ritacco V, Di Lonardo M, Reniero A, Ambroggi M, Barrera L, Dambrosi A, Lopez B, Isola N, de Kantor IN (1997) Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 176(3):637\u2013642","journal-title":"J Infect Dis"},{"issue":"4","key":"1_CR234","first-page":"402","volume":"65","author":"EH Robitzek","year":"1952","unstructured":"Robitzek EH, Selikoff IJ (1952) Hydrazine derivatives of isonicotinic acid (rimifon marsilid) in the treatment of active progressive caseous-pneumonic tuberculosis; a preliminary report. Am Rev Tuberc 65(4):402\u2013428","journal-title":"Am Rev Tuberc"},{"issue":"2","key":"1_CR235","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212363","volume":"14","author":"WD Roe","year":"2019","unstructured":"Roe WD, Lenting B, Kokosinska A, Hunter S, Duignan PJ, Gartrell B, Rogers L, Collins DM, de Lisle GW, Gedye K, Price-Carter M (2019) Pathology and molecular epidemiology of mycobacterium pinnipedii tuberculosis in native New Zealand marine mammals. PLoS One 14(2):e0212363","journal-title":"PLoS One"},{"issue":"1","key":"1_CR237","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0025-7125(16)34193-1","volume":"43","author":"EH Runyon","year":"1959","unstructured":"Runyon EH (1959) Anonymous mycobacteria in pulmonary disease. Med Clin North Am 43(1):273\u2013290","journal-title":"Med Clin North Am"},{"issue":"12","key":"1_CR238","first-page":"785","volume":"15","author":"M Saffari","year":"2012","unstructured":"Saffari M, Pakpour AH (2012) Avicenna\u2019s canon of medicine: a look at health, public health, and environmental sanitation. Arch Iran Med 15(12):785\u2013789. PMID: 23199255","journal-title":"Arch Iran Med"},{"issue":"1","key":"1_CR239","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijmy.ijmy_235_22","volume":"12","author":"V Sakthivadivel","year":"2023","unstructured":"Sakthivadivel V, Gaur A, Geetha J (2023) Tuberculosis in elderly population: a cross-sectional comparative study. Int J Mycobacteriol. 12(1):38\u201342","journal-title":"Int J Mycobacteriol."},{"issue":"2","key":"1_CR240","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/ijmy.ijmy_67_23","volume":"12","author":"J Samanta","year":"2023","unstructured":"Samanta J, Mitra S, Chakraborty S, Kumar C, Yashavanth KY, Das S (2023) Pulmonary tuberculosis among patients of tubercular pleural effusion: a single-center experience. Intl J Mycobacteriol 12(2):139\u2013143","journal-title":"Intl J Mycobacteriol"},{"issue":"11","key":"1_CR241","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10916-022-01870-8","volume":"46","author":"KC Santosh","year":"2022","unstructured":"Santosh KC, Allu S, Rajaraman S, Antani S (2022) Advances in deep learning for tuberculosis screening using chest X-rays: the last 5 years review. J Med Syst 46(11):82","journal-title":"J Med Syst"},{"issue":"6","key":"1_CR242","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cmi.2017.10.030","volume":"24","author":"G Satta","year":"2018","unstructured":"Satta G, Lipman M, Smith GP, Arnold C, Kon OM, McHugh TD (2018) Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential? Clin Microbiol Infect 24(6):604\u2013609","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1_CR243","first-page":"101","volume":"5","author":"S Satyanarayana","year":"2020","unstructured":"Satyanarayana S, Thekkur P, Kumar AMV, Lin Y, Dlodlo RA, Khogali M, Zachariah R, Harries AD (2020) An opportunity to END TB: using the sustainable development goals for action on socio-economic determinants of TB in high burden countries in WHO South-East Asia and the Western Pacific regions. Trop Med Infect Dis 5(2):101","journal-title":"Trop Med Infect Dis"},{"issue":"2","key":"1_CR244","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4046\/trd.2022.0148","volume":"86","author":"MF Sazali","year":"2023","unstructured":"Sazali MF, Rahim SSSA, Mohammad AH, Kadir F, Payus AO, Avoi R, Jeffree MS, Omar A, Ibrahim MY, Atil A, Tuah NM, Dapari R, Lansing MG, Rahim AAA, Azhar ZI (2023) Improving tuberculosis medication adherence: The potential of integrating digital technology and health belief model. Tuberc Respir Dis (Seoul) 86(2):82\u201393","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1_CR245","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3389\/fimmu.2017.01755","volume":"8","author":"UE Schaible","year":"2017","unstructured":"Schaible UE, Linnemann L, Redinger N, Patin EC, Dallenga T (2017) Strategies to improve vaccine efficacy against tuberculosis by targeting innate immunity. Front Immunol 8:1755","journal-title":"Front Immunol"},{"key":"1_CR246","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.blo.0000175887.98112.fe","volume":"437","author":"A Schatz","year":"2005","unstructured":"Schatz A, Bugie E, Waksman SA (2005) Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944. Clin Orthop Relat Res 437:3\u20136","journal-title":"Clin Orthop Relat Res"},{"issue":"26","key":"1_CR247","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1002\/anie.201101740","volume":"50","author":"E Schmitt","year":"2011","unstructured":"Schmitt E, Riwanto M, Sambandamurthy V, Roggo S, Miault C, Zwingelstein C, Krastel P, Noble C, Beer D, Rao S, Au M, Niyomrattanakit P, Lim V, Zheng J, Jeffery D, Pethe K, Camacho L (2011) The natural product Cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the Caseinolytic protease. Angew Chem Int Ed Engl 50(26):5889\u20135891","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"1_CR248","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.3390\/ijms24076302","volume":"24","author":"F Sciarra","year":"2023","unstructured":"Sciarra F, Campolo F, Franceschini E, Carlomagno F, Venneri MA (2023) Gender-specific impact of sex hormones on the immune system. Int J Mol Sci 24(7):6302","journal-title":"Int J Mol Sci"},{"key":"1_CR249","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12982-025-00593-8","volume":"22","author":"GY Scott","year":"2025","unstructured":"Scott GY, Aborode AT, Adesola RO, Benson I, Omulepu I, Ajayi OO, Nibokun EO et al (2025) Diagnostic innovations for tuberculosis in sub-Saharan Africa. Discov Public Health 22:188","journal-title":"Discov Public Health"},{"issue":"3","key":"1_CR250","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/ijmy.ijmy_78_20","volume":"9","author":"S Selmane","year":"2020","unstructured":"Selmane S, L\u2019Hadj M (2020) Epidemiology and clinical characteristics of tuberculosis in Leon Bernard tuberculosis unit in Algeria. Intl J Mycobacteriol 9(3):254\u2013260","journal-title":"Intl J Mycobacteriol"},{"issue":"9","key":"1_CR251","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863","volume":"5","author":"KJ Seung","year":"2015","unstructured":"Seung KJ, Keshavjee S, Rich ML (2015) Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med 5(9):a017863","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"1_CR252","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1604544","volume":"376","author":"NS Shah","year":"2017","unstructured":"Shah NS, Auld SC, Brust JC, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T, Morris N, Mpangase P, van der Meulen H, Omar SV, Brown TS, Narechania A, Shaskina E, Kapwata T, Kreiswirth B, Gandhi NR (2017) Transmission of extensively drug-resistant tuberculosis in South Africa. N Engl J Med 376(3):243\u2013253","journal-title":"N Engl J Med"},{"issue":"1","key":"1_CR253","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/s12864-019-6407-5","volume":"20","author":"TT Silva-Pereira","year":"2019","unstructured":"Silva-Pereira TT, Ikuta CY, Zimpel CK, Camargo NCS, de Souza Filho AF, Ferreira Neto JS, Heinemann MB, Guimar\u00e3es AMS (2019) Genome sequencing of mycobacterium pinnipedii strains: genetic characterization and evidence of superinfection in a south American sea lion (Otaria flavescens). BMC Genomics 20(1):1030","journal-title":"BMC Genomics"},{"issue":"2","key":"1_CR254","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02289-23","volume":"12","author":"TT Silva-Pereira","year":"2024","unstructured":"Silva-Pereira TT, Soler-Camargo NC, Guimar\u00e3es AMS (2024) Diversification of gene content in the Mycobacterium tuberculosis complex is determined by phylogenetic and ecological signatures. Microbiol Spectr 12(2):e0228923","journal-title":"Microbiol Spectr"},{"issue":"1","key":"1_CR255","first-page":"198","volume":"15","author":"S Singal","year":"2025","unstructured":"Singal S, Modi N, Singal A, Agrawal H (2025) Investigating the prevalence of tuberculosis in urban slums: a pathological cross-sectional approach. Eur J Cardiovasc Med 15(1):198\u2013202","journal-title":"Eur J Cardiovasc Med"},{"issue":"1","key":"1_CR256","doi-asserted-by":"publisher","DOI":"10.1016\/j.aichem.2023.100039","volume":"2","author":"S Singh","year":"2024","unstructured":"Singh S, Gupta H, Sharma P, Sahi S (2024) Advances in artificial intelligence (AI)-assisted approaches in drug screening. Artif Intellig Chem 2(1):100039","journal-title":"Artif Intellig Chem"},{"issue":"8","key":"1_CR257","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1128\/JCM.00638-09","volume":"47","author":"NH Smith","year":"2009","unstructured":"Smith NH, Crawshaw T, Parry J, Birtles RJ (2009) Mycobacterium microti: more diverse than previously thought. J Clin Microbiol 47(8):2551\u20132559","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1_CR258","doi-asserted-by":"publisher","first-page":"1702352","DOI":"10.1183\/13993003.02352-2017","volume":"51","author":"KJ Snow","year":"2018","unstructured":"Snow KJ, Sismanidis C, Denholm J, Sawyer SM, Graham SM (2018) The incidence of tuberculosis among adolescents and young adults: a global estimate. Eur Respir J 51(2):1702352","journal-title":"Eur Respir J"},{"issue":"9","key":"1_CR259","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000421","volume":"3","author":"R Sodhi","year":"2024","unstructured":"Sodhi R, Vatsyayan V, Panibatla V, Sayyad K, Williams J, Pattery T, Pal A (2024) Impact of a pilot mHealth intervention on treatment outcomes of TB patients seeking care in the private sector using propensity scores matching-evidence collated from New Delhi, India. PLOS Digit Health 3(9):e0000421","journal-title":"PLOS Digit Health"},{"issue":"9","key":"1_CR260","first-page":"E354","volume":"7","author":"G Sotgiu","year":"2015","unstructured":"Sotgiu G, D\u2019Ambrosio L, Centis R, Mura I, Castiglia P, Spanevello A, Migliori GB (2015) The multidrug-resistant tuberculosis threat: old problems and new solutions. J Thorac Dis 7(9):E354\u2013E360","journal-title":"J Thorac Dis"},{"issue":"5","key":"1_CR261","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/vaccines11051013","volume":"11","author":"S Srivastava","year":"2023","unstructured":"Srivastava S, Dey S, Mukhopadhyay S (2023) Vaccines against tuberculosis: where are we now? Vaccine 11(5):1013","journal-title":"Vaccine"},{"issue":"1","key":"1_CR262","first-page":"CD009593","volume":"14","author":"KR Steingart","year":"2014","unstructured":"Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N (2014) Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 14(1):CD009593","journal-title":"Cochrane Database Syst Rev"},{"key":"1_CR263","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923968","volume":"10","author":"Q Sun","year":"2022","unstructured":"Sun Q, Yan J, Liao X, Wang C, Wang C, Jiang G, Dong L, Wang F, Huang H, Wang G, Pan J (2022) Trends and species diversity of non-tuberculous mycobacteria isolated from respiratory samples in northern China, 2014\u20132021. Front Public Health 10:923968","journal-title":"Front Public Health"},{"key":"1_CR264","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1101\/2023.10.12.23296976","volume":"16","author":"TY Sun","year":"2023","unstructured":"Sun TY, Hardin J, Nieva HR, Natarajan K, Cheng RF, Ryan P, Elhadad N (2023) Large-scale characterization of gender differences in diagnosis prevalence and time to diagnosis. medRxiv [Preprint] 16:2023. https:\/\/doi.org\/10.1101\/2023.10.12.23296976","journal-title":"medRxiv [Preprint]"},{"key":"1_CR266","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40248-016-0081-0","volume":"11","author":"WM Sweileh","year":"2016","unstructured":"Sweileh WM, AbuTaha AS, Sawalha AF, Al-Khalil S, Al-Zyoud SH (2016) Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug-resistant tuberculosis (2006\u20132015). Multidiscip Respir Med 11:45","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"1_CR267","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/AAC.2.1.29","volume":"2","author":"K Takayama","year":"1972","unstructured":"Takayama K, Wang L, David HL (1972) Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2(1):29\u201335","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1_CR268","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1183\/09031936.00193413","volume":"43","author":"T Tanimura","year":"2014","unstructured":"Tanimura T, Jaramillo E, Weil D, Raviglione M, L\u00f6nnroth K (2014) Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J 43(6):1763\u20131775","journal-title":"Eur Respir J"},{"key":"1_CR269","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12879-024-10288-1","volume":"25","author":"JW Taylor","year":"2025","unstructured":"Taylor JW, Wright GEL, Lim LL, Denholm JT (2025) A systematic review of the utility of antituberculosis therapy for presumed tuberculous uveitis. BMC Infect Dis 25:112","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1_CR270","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1021\/acsinfecdis.4c00466","volume":"10","author":"TKA Teibo","year":"2024","unstructured":"Teibo TKA, Andrade RLP, Rosa RJ, de Abreu PD, Olayemi OA, Alves YM, Vaz Tavares RB, da Costa FBP, Dias Moura HS, Ferezin LP, T\u00e1rtaro AF, de Campos MCT, Ribeiro NM, Berra TZ, Arc\u00eancio RA (2024) Barriers that interfere with access to tuberculosis diagnosis and treatment across countries globally: a systematic review. ACS Infect Dis 10(8):2600\u20132614","journal-title":"ACS Infect Dis"},{"key":"1_CR271","volume":"36","author":"AKJ Teo","year":"2023","unstructured":"Teo AKJ, Morishita F, Islam T, Viney K, Ong CWM, Kato S, Kim H, Liu Y, Oh KH, Yoshiyama T, Ohkado A, Rahevar K, Kawatsu L, Yanagawa M, Prem K, Yi S, Tran HTG, Marais BJ (2023) Tuberculosis in older adults: challenges and best practices in the Western Pacific region. Lancet Reg Health West Pac 36:100770","journal-title":"Lancet Reg Health West Pac"},{"issue":"2","key":"1_CR272","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/ijmy.ijmy_70_25","volume":"14","author":"SC Theorupun","year":"2025","unstructured":"Theorupun SC, Massi MN, Nurhasanah A, Syamsuri F, Hatta M, Rasita YD et al (2025) PPE18 and PepA variations in Mycobacterium tuberculosis clinical isolates from Makassar, Indonesia: challenges for immune recognition and vaccine development. Intl J Mycobacteriol 14(2):191\u2013200","journal-title":"Intl J Mycobacteriol"},{"key":"1_CR273","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/saje.12385","volume":"92","author":"H Ting","year":"2024","unstructured":"Ting H, Bozzola M, Ravetti C (2024) Tuberculosis and labour market participation: evidence from South Africa. South Afr J Econ 92:444","journal-title":"South Afr J Econ"},{"key":"1_CR274","volume-title":"StatPearls [Internet]","author":"EH Tobin","year":"2024","unstructured":"Tobin EH, Tristram D (2024) Tuberculosis Overview. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). [Cited 2025 May?]. Available from: NCBI Bookshelf"},{"issue":"4","key":"1_CR275","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.meegid.2011.05.025","volume":"12","author":"E Tortoli","year":"2012","unstructured":"Tortoli E (2012) Phylogeny of the genus mycobacterium: many doubts, few certainties. Infect Genet Evol 12(4):827\u2013831","journal-title":"Infect Genet Evol"},{"issue":"4","key":"1_CR276","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1128\/CMR.00035-14","volume":"27","author":"E Tortoli","year":"2014","unstructured":"Tortoli E (2014) Microbiological features and clinical relevance of new species of the genus mycobacterium. Clin Microbiol Rev 27(4):727\u2013752","journal-title":"Clin Microbiol Rev"},{"key":"1_CR277","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.103983","volume":"75","author":"E Tortoli","year":"2019","unstructured":"Tortoli E, Meehan CJ, Grottola A, Fregni Serpini G, Fabio A, Trovato A, Pecorari M, Cirillo DM (2019) Genome-based taxonomic revision detects a number of synonymous taxa in the genus mycobacterium. Infect Genet Evol 75:103983","journal-title":"Infect Genet Evol"},{"issue":"11","key":"1_CR278","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000328","volume":"2","author":"RW Truman","year":"2008","unstructured":"Truman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, Gillis TP (2008) Enumeration of mycobacterium leprae using real-time PCR. PLoS Negl Trop Dis 2(11):e328","journal-title":"PLoS Negl Trop Dis"},{"key":"1_CR1010","doi-asserted-by":"crossref","unstructured":"Tumuhimbise W, Atwine D, Kaggwa F, Musiimenta A (2023) Acceptability and feasibility of a mobile health application for enhancing public private mix for TB care among healthcare Workers in Southwestern Uganda. BMC Digit Health 1(1):9. https:\/\/doi.org\/10.1186\/s44247-023-00009-0. Epub 2023 Mar 3. PMID: 38014370; PMCID: PMC9982777","DOI":"10.1186\/s44247-023-00009-0"},{"issue":"12","key":"1_CR280","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S2213-2600(19)30366-2","volume":"7","author":"CD Tweed","year":"2019","unstructured":"Tweed CD, Dawson R, Burger DA, Conradie A, Crook AM, Mendel CM, Conradie F, Diacon AH, Ntinginya NE, Everitt DE, Haraka F (2019) Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. Lancet Respir Med 7(12):1048\u20131058","journal-title":"Lancet Respir Med"},{"issue":"3","key":"1_CR281","doi-asserted-by":"publisher","first-page":"ofx137","DOI":"10.1093\/ofid\/ofx137","volume":"4","author":"L Uden","year":"2017","unstructured":"Uden L, Barber E, Ford N, Cooke GS (2017) Risk of tuberculosis infection and disease for health care workers: an updated meta-analysis. Open Forum Infect Dis 4(3):ofx137","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"1_CR282","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cid\/cir889","volume":"54","author":"ZF Udwadia","year":"2012","unstructured":"Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C (2012) Totally drug-resistant tuberculosis in India. Clin Infect Dis 54(4):579\u2013581","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1_CR283","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21010\/ajid.v15i2.5","volume":"15","author":"KO Ugwu","year":"2021","unstructured":"Ugwu KO, Agbo MC, Ezeonu IM (2021) Prevalence of tuberculosis, drug-resistant tuberculosis and HIV\/TB co-infection in Enugu Nigeria. Afr J Infect Dis 15(2):24\u201330","journal-title":"Afr J Infect Dis"},{"issue":"8","key":"1_CR284","doi-asserted-by":"publisher","first-page":"ofaa264","DOI":"10.1093\/ofid\/ofaa264","volume":"7","author":"A Vaisman","year":"2020","unstructured":"Vaisman A, Barry P, Flood J (2020) Assessing complexity among patients with tuberculosis in California, 1993\u20132016. Open Forum Infect Dis 7(8):ofaa264","journal-title":"Open Forum Infect Dis"},{"key":"1_CR1012","doi-asserted-by":"crossref","unstructured":"van Arkel C, Storms I, Kurver L, Smeenk F, Wielders P, Hoefsloot W, Carpaij N, Boeree MJ, van Crevel R, van Laarhoven A, Magis-Escurra C (2024) Elderly patients with tuberculosis in a low-incidence country: clinical characteristics, inflammation and outcome. J Infect 89(2):106200. https:\/\/doi.org\/10.1016\/j.jinf.2024.106200. Epub 2024 Jun 18. PMID: 38901573","DOI":"10.1016\/j.jinf.2024.106200"},{"issue":"4","key":"1_CR286","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3201\/eid1804.110888","volume":"18","author":"J van Ingen","year":"2012","unstructured":"van Ingen J, Rahim Z, Mulder a, Boeree MJ, Simeone R, Brosch R, van Soolingen D. (2012) Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies. Emerg Infect Dis 18(4):653\u2013655","journal-title":"Emerg Infect Dis"},{"key":"1_CR287","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107741","volume":"152","author":"A Van Rie","year":"2025","unstructured":"Van Rie A, Warren R, Meurrens MV, Potgieter T (2025) The role of AI in combatting RR-TB epidemics. Int J Infect Dis 152:107741","journal-title":"Int J Infect Dis"},{"key":"1_CR1011","doi-asserted-by":"crossref","unstructured":"Vanden Driessche K, Persson A, Marais BJ, Fink PJ, Urdahl KB (2013) Immune vulnerability of infants to tuberculosis. Clin Dev Immunol 2013:781320. https:\/\/doi.org\/10.1155\/2013\/781320. Epub 2013 May 13. PMID: 23762096; PMCID: PMC3666431","DOI":"10.1155\/2013\/781320"},{"key":"1_CR288","volume-title":"The lifecycle of medical sciences","author":"AA Velayati","year":"2023","unstructured":"Velayati AA (2023) Hospitalization, diagnosis, treatment, and surgery in Iran. In: The lifecycle of medical sciences, 1st edn. Academic. ISBN 9780443153051","edition":"1"},{"key":"1_CR289","volume-title":"Nontuberculous mycobacteria (NTM): microbiological, clinical and geographical distribution","year":"2019","unstructured":"Velayati AA, Farnia P (eds) (2019) Nontuberculous mycobacteria (NTM): microbiological, clinical and geographical distribution, 1st edn. Academic, London. Paperback ISBN: 9780128146927. eBook ISBN: 9780128146934","edition":"1"},{"issue":"2","key":"1_CR290","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1378\/chest.08-2427","volume":"136","author":"AA Velayati","year":"2009","unstructured":"Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, ZiaZarifi AH, Hoffner SE (2009) Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136(2):420\u2013425","journal-title":"Chest"},{"issue":"2","key":"1_CR291","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijmyco.2013.04.005","volume":"2","author":"AA Velayati","year":"2013","unstructured":"Velayati AA, Farnia P, Masjedi MR (2013) Totally drug-resistant tuberculosis (TDR-TB): a debate on global health communities. Int J Mycobacteriol. 2(2):71\u201372","journal-title":"Int J Mycobacteriol."},{"issue":"12","key":"1_CR292","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114428","volume":"9","author":"AA Velayati","year":"2014","unstructured":"Velayati AA, Farnia P, Mozafari M, Malekshahian D, Seif S, Rahideh S, Mirsaeidi M (2014) Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One 9(12):e114428","journal-title":"PLoS One"},{"issue":"1","key":"1_CR293","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijmyco.2014.12.005","volume":"4","author":"AA Velayati","year":"2015","unstructured":"Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M (2015a) Nontuberculous mycobacteria in Middle East: current situation and future challenges. Int J Mycobacteriol 4(1):7\u201317","journal-title":"Int J Mycobacteriol"},{"key":"1_CR294","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/254285","volume":"2015","author":"AA Velayati","year":"2015","unstructured":"Velayati AA, Farnia P, Mozafari M, Mirsaeidi M (2015b) Nontuberculous mycobacteria isolation from clinical and environmental samples in Iran: twenty years of surveillance. Biomed Res Int 2015:254285","journal-title":"Biomed Res Int"},{"key":"1_CR295","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jgar.2017.10.006","volume":"12","author":"AA Velayati","year":"2018","unstructured":"Velayati AA, Farnia P, Hoffner S (2018) Drug-resistant Mycobacterium tuberculosis: epidemiology and role of morphological alterations. J Glob Antimicrob Resist 12:192\u2013196","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"1_CR296","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4103\/ijmy.ijmy_212_24","volume":"13","author":"AA Velayati","year":"2024","unstructured":"Velayati AA, Mitaria S, Farnia P, Farnia P, Ghanavi J, Maleknia M, Murase Y, Hoffner S (2024) Exploring the genetic landscape of Mycobacterium tuberculosis: unlocking the differences between latent and active tuberculosis. Int J Mycobacteriol. 13(4):410","journal-title":"Int J Mycobacteriol."},{"issue":"2","key":"1_CR297","first-page":"32","volume":"10","author":"SL Vidal","year":"2025","unstructured":"Vidal SL, Batista LCF, Lages DDS, Bortolomai BE, Bueno IDC, Niitsuma ENA, Oliveira NGD, Baptista IMFD, Lana FCF (2025) Molecular detection of mycobacterium leprae and the process of infection and illness in contacts of leprosy patients: a systematic review. Trop Med Infect Dis 10(2):32","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"1_CR298","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100148","volume":"2","author":"LA Vonnahme","year":"2023","unstructured":"Vonnahme LA, Raykin J, Jones M, Oakley J, Puro J, Langer A et al (2023) Using electronic health record data to measure the latent tuberculosis infection care Cascade in safety-net primary care clinics. AJPM Focus 2(4):100148","journal-title":"AJPM Focus"},{"issue":"10","key":"1_CR299","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","volume":"15","author":"TM Walker","year":"2015","unstructured":"Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo EC, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CLC, Bowden R, Drobniewski FA, Allix-B\u00e9guec C, Gaudin C, Parkhill J, Diel R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TEA, Modernizing Medical Microbiology (MMM) informatics Group (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15(10):1193\u20131202","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1_CR300","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/infdis\/166.2.405","volume":"166","author":"RJ Wallace","year":"1992","unstructured":"Wallace RJ, Brown BA, Onyi GO (1992) Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166(2):405\u2013412","journal-title":"J Infect Dis"},{"issue":"6","key":"1_CR301","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069381","volume":"13","author":"M Wang","year":"2023","unstructured":"Wang M, Chen X, Sun Y, Wang Q, Liu G (2023) Functions, advantages and challenges facing private healthcare organisations in China\u2019s healthcare system: a qualitative analysis through open-ended questionnaires. BMJ Open 13(6):e069381","journal-title":"BMJ Open"},{"issue":"5","key":"1_CR303","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007280","volume":"16","author":"T Wessler","year":"2020","unstructured":"Wessler T, Joslyn LR, Borish HJ, Gideon HP, Flynn JL, Kirschner DE, Linderman JJ (2020) A computational model tracks whole-lung Mycobacterium tuberculosis infection and predicts factors that inhibit dissemination. PLoS Comput Biol 16(5):e1007280","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"1_CR304","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.4049\/jimmunol.166.3.1951","volume":"166","author":"JE Wigginton","year":"2001","unstructured":"Wigginton JE, Kirschner D (2001) A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol 166(3):1951\u20131967","journal-title":"J Immunol"},{"key":"1_CR306","doi-asserted-by":"publisher","first-page":"265","DOI":"10.15585\/mmwr.mm7312a4","volume":"73","author":"PM Williams","year":"2024","unstructured":"Williams PM (2024) Tuberculosis\u2014United States, 2023. MMWR Morb Mortal Wkly Rep 73:265","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1_CR307","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5588\/ijtld.11.0178","volume":"16","author":"DA Williamson","year":"2012","unstructured":"Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O et al (2012) Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Intl J Tubercul Lung Dis 16(2):216\u2013220","journal-title":"Intl J Tubercul Lung Dis"},{"issue":"5","key":"1_CR308","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1128\/JCM.02993-14","volume":"53","author":"AA Witney","year":"2015","unstructured":"Witney AA, Gould KA, Arnold A, Coleman D, Delgado R, Dhillon J, Pond MJ, Pope CF, Planche TD, Stoker NG, Cosgrove CA, Butcher PD, Harrison TS, Hinds J (2015) Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases. J Clin Microbiol 53(5):1473\u20131483","journal-title":"J Clin Microbiol"},{"key":"1_CR1007","unstructured":"World Health Organization (1996) Global tuberculosis control: WHO report 1996. World Health Organization, Geneva. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/62065"},{"key":"1_CR309","volume-title":"Nutritional care and support for patients with tuberculosis [internet]","author":"World Health Organization","year":"2013","unstructured":"World Health Organization (2013) Nutritional care and support for patients with tuberculosis [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241565400"},{"key":"1_CR310","volume-title":"Global tuberculosis report 2014 [internet]","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014a) Global tuberculosis report 2014 [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/137094"},{"key":"1_CR311","volume-title":"Xpert MTB\/RIF implementation manual: technical and operational \u2018how-to\u2019: practical considerations [internet]","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014b) Xpert MTB\/RIF implementation manual: technical and operational \u2018how-to\u2019: practical considerations [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/112469"},{"key":"1_CR312","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [internet]","author":"World Health Organization","year":"2014","unstructured":"World Health Organization (2014c) Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241548809"},{"key":"1_CR313","volume-title":"Implementing the end TB strategy: the essentials [internet]","author":"World Health Organization","year":"2015","unstructured":"World Health Organization (2015) Implementing the end TB strategy: the essentials [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/206499"},{"key":"1_CR314","volume-title":"The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin: policy update [internet]","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin: policy update [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241511260"},{"key":"1_CR315","volume-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment [internet]","author":"World Health Organization","year":"2019","unstructured":"World Health Organization (2019) WHO consolidated guidelines on drug-resistant tuberculosis treatment [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/iris.who.int\/handle\/10665\/311389"},{"key":"1_CR1008","unstructured":"World Health Organization (2020) Consolidated guidelines on tuberculosis treatment (Module 4: drug-resistant TB treatment). World Health Organization, Geneva. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240007048"},{"key":"1_CR316","volume-title":"WHO consolidated guidelines on tuberculosis: module 3, diagnosis: rapid diagnostics for tuberculosis detection [internet]","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021a) WHO consolidated guidelines on tuberculosis: module 3, diagnosis: rapid diagnostics for tuberculosis detection [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240037021"},{"key":"1_CR317","volume-title":"WHO operational handbook on tuberculosis: module 2, management of tuberculosis in children and adolescents [internet]","author":"World Health Organization","year":"2021","unstructured":"World Health Organization (2021b) WHO operational handbook on tuberculosis: module 2, management of tuberculosis in children and adolescents [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240036949"},{"key":"1_CR318","volume-title":"Drug-resistant tuberculosis treatment, 2022 update [internet]","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022a) Drug-resistant tuberculosis treatment, 2022 update [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240045061"},{"key":"1_CR319","volume-title":"WHO consolidated guidelines on tuberculosis: module 4, treatment\u2014drugs and regimens [internet]","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022b) WHO consolidated guidelines on tuberculosis: module 4, treatment\u2014drugs and regimens [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240051303"},{"key":"1_CR320","volume-title":"Global tuberculosis report 2023 [internet]","author":"World Health Organization","year":"2023","unstructured":"World Health Organization (2023) Global tuberculosis report 2023 [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/teams\/tb-reports\/global-tuberculosis-report-2023"},{"key":"1_CR321","volume-title":"Global tuberculosis report 2024 [internet]","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) Global tuberculosis report 2024 [internet]. WHO, Geneva. [cited 2025 Jul 9]. Available from: https:\/\/www.who.int\/teams\/tb-reports\/global-tuberculosis-report-2024"},{"issue":"3","key":"1_CR322","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/heapol\/czp057","volume":"25","author":"E Wouters","year":"2010","unstructured":"Wouters E, van Rensburg HC, Meulemans H (2010) The National Strategic Plan of South Africa: what are the prospects of success after the repeated failure of previous AIDS policy? Health Policy Plan 25(3):171\u2013185","journal-title":"Health Policy Plan"},{"issue":"15","key":"1_CR323","doi-asserted-by":"publisher","first-page":"1567592","DOI":"10.3389\/fcimb.2025.1567592","volume":"8","author":"Z Yang","year":"2025","unstructured":"Yang Z, Li J, Shen J, Cao H, Wang Y, Hu S, Du Y, Wang Y, Yan Z, Xie L, Li Q, Gomaa SE, Liu S, Li X, Li J (2025) Recent progress in tuberculosis diagnosis: insights into blood-based biomarkers and emerging technologies. Front Cell Infect Microbiol 8(15):1567592","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1_CR324","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41479-024-00133-z","volume":"16","author":"J Yayan","year":"2024","unstructured":"Yayan J, Franke KJ, Berger M, Windisch W, Rasche K (2024) Early detection of tuberculosis: a systematic review. Pneumonia (Nathan) 16(1):11","journal-title":"Pneumonia (Nathan)"},{"issue":"5","key":"1_CR325","first-page":"523","volume":"65","author":"RL Yeager","year":"1952","unstructured":"Yeager RL, Munroe WG, Dessau FI (1952) Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis. Am Rev Tuberc 65(5):523\u2013546. PMID: 14924175","journal-title":"Am Rev Tuberc"},{"issue":"1","key":"1_CR326","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12913-025-12298-4","volume":"25","author":"AN Yirsaw","year":"2025","unstructured":"Yirsaw AN, Lakew G, Getachew E, Kasaye MD, Enyew EB, Getachew D, Tareke AA (2025) Health extension workers job satisfaction and associated factors in Ethiopia: a systematic review and meta-analysis. BMC Health Serv Res 25(1):144","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1_CR328","doi-asserted-by":"publisher","first-page":"27723","DOI":"10.1038\/s41598-024-75228-0","volume":"14","author":"M Zhang","year":"2024","unstructured":"Zhang M, Adroub S, Ummels R, Asaad M, Song L, Pain A, Bitter W, Guan Q, Abdallah AM (2024) Comprehensive pan-genome analysis of Mycobacterium marinum: insights into genomic diversity, evolution, and pathogenicity. Sci Rep 14(1):27723","journal-title":"Sci Rep"},{"key":"1_CR329","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/IDR.S504632","volume":"18","author":"H Zhang","year":"2025","unstructured":"Zhang H, Guan W, Zhou J (2025) Advances in the diagnosis of latent tuberculosis infection. Infect Drug Resist. 18:483\u2013493","journal-title":"Infect Drug Resist."},{"key":"1_CR1001","doi-asserted-by":"crossref","unstructured":"Zheng Y, Emam M, Lu D, Tian M, Wang K, Peng X (2023) Analysis of the effect of temperature on tuberculosis incidence by distributed lag non-linear model in Kashgar city, China. Environ Sci Pollut Res 30:11530\u201311541. https:\/\/doi.org\/10.1007\/s11356-022-22849-5","DOI":"10.1007\/s11356-022-22849-5"},{"issue":"6","key":"1_CR331","first-page":"604","volume":"55","author":"MR Zimmerman","year":"1979","unstructured":"Zimmerman MR (1979) Pulmonary and osseous tuberculosis in an Egyptian mummy. Bull N Y Acad Med 55(6):604\u2013608. PMID: 380700; PMCID: PMC1807652","journal-title":"Bull N Y Acad Med"},{"key":"1_CR1003","unstructured":"Zopf W (1883) Die Spaltpilze, 2nd edn. J.U. Kern\u2019s Verlag, Breslau"},{"issue":"8","key":"1_CR332","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1056\/NEJMra1200894","volume":"368","author":"A Zumla","year":"2012","unstructured":"Zumla A, Raviglione M, Hafner R, von Reyn CF (2012) Tuberculosis. N Engl J Med 368(8):745\u2013755","journal-title":"N Engl J Med"},{"key":"1_CR333","doi-asserted-by":"crossref","unstructured":"Zumla A, Sahu S, Ditiu L, Singh U, Park YJ, Yeboah-Manu D, et al (2025) Inequities underlie the alarming resurgence of tuberculosis as the world\u2019s top cause of death from an infectious disease: breaking the silence and addressing the underlying root causes. IJID14(Suppl 2):100587. https:\/\/doi.org\/10.1016\/j.ijregi.2025.100587. PMID: 40201557; PMCID: PMC1197369","DOI":"10.1016\/j.ijregi.2025.100587"}],"container-title":["Advances in Experimental Medicine and Biology","Proteins in Mycobacterium Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-96883-9_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:07:01Z","timestamp":1779430021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-96883-9_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"ISBN":["9783031968822","9783031968839"],"references-count":330,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-96883-9_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"10 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}